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FECAL QUALITY, AND POSTPRANDIAL GLYCEMIA 
 
 
 
Obesity is the most prevalent nutritional disorder encountered in small animal 
medicine.  Problems related with obesity are the higher incidence of morbidity and 
mortality.  Nutritional and physical activity interventions have been common strategies 
employed; however, they have shown low compliance rates.  Because of it more attention 
has been given to the nutrient composition of diets. Using the canine model, three 
experiments were conducted to examine the effect of fish oil or barley on protein and 
lipid metabolism, as well as postprandial glycemia, and nutrient digestibility in mature 
and in young adult dogs. 
 
In Exp. 1, seven female dogs were randomly assigned to one of two 
isonitrogenous and isocaloric diets, control (CO) or fish oil (FO), in a crossover design.  
Animals fed the FO diet tended to be more sensitive to glucose, showing a lower glucose 
half life. Cholesterol and HDL decreased (p<0.05) on the FO treatment.  Overall, the 
supplementation of fish oil may improve glucose clearance rate and is effective in 
decreasing cholesterol in mature overweight dogs. 
 
In Exp. 2, eight female Beagles were randomly assigned to one of two 
isonitrogenous and isocaloric diets, control (CO) or fish oil (FO), in a crossover design. 
Overall, feeding a FO containing diet showed a protective effect against the rise of 
plasma CHOL and it increased plasma ghrelin levels.  However, it did not appear to 
improve protein metabolism or postprandial glycemia in adult lean dogs. 
 
 In Exp. 3, sixteen female dogs were randomly assigned to four experimental diets; 
control (40% corn) or three levels of barley (10, 20, 40%). The data suggest that inclusion 
of barley up to 40% in diets for adult dogs is well tolerated and does not negatively 
impact nutrient digestibility of the diets.  However, inclusion of barley did not improve 
aspects related to fecal odor, postprandial glycemia, or plasma cholesterol. 
  Overall, the research presented herein suggests that different nutritional strategies 
- dietary lipid or carbohydrate manipulation - may be beneficial in ameliorating health 
issues (e.g., hyperlipidemia) or in improving the health status of dogs (e.g., gut health by 
increased SCFA production).  
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CHAPTER 1: INTRODUCTION 
 
In U. S., approximately, 68% of adult humans are obese (Flegal et al., 2010).  
Similarly, it is estimated that 55% of dogs and 53% of cats are overweight or obese 
(Calabash, 2011).  Annually, human obesity costs 150 billion dollars for the U. S. 
government (CDC, 2011), and Veterinary Pet Insurance claims are over 14 million 
dollars for weight-related health problems (Ward, 2010).  Obesity has become the leading 
health threat in pets and the major cause of death in humans in the 21th century (Ward, 
2010 and CDC, 2010), as well as the most common form of malnutrition in dogs (Case et 
al., 2000) and the most prevalent nutritional disorder encountered in small animal 
medicine (Jeusette et al., 2005). 
The obesity epidemics have been closely related to the contemporary lifestyle of 
Western populations, which has been characterized by lower physical activity and 
increased consumption of a highly processed and caloric-dense diet.  It has been 
suggested that before the development of modern agriculture and animal husbandry, 
dietary choices were limited to seasonal availability of plant and animal food sources that 
were minimally (if at all) processed; a scenario that has changed with the introduction of 
modern agriculture and animal husbandry, and more recently, with the advent of 
industrialization.  All of which have resulted in profound changes in social and 
environmental conditions that set up the stage for a drastic nutritional shift including: 
glycemic load, fatty acid composition, and fiber content (Cordain et al., 2005). 
According to the similarities between human and pet obesity, it sounds fair to 
state that dogs and cats have also been “Westernized” by their owners.  Companion 
animals have been exposed to highly palatable, energy-dense, human-like foods in 
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conjunction with a decreased energy requirement mainly due to sedentary life, and 
neutering and spaying practices.  Similar to humans, overweight or obese animals are 
more predisposed to develop other chronic illnesses, which contributes to the estimated 
deaths associated with obesity. 
In order to control and to prevent obesity, nutritional and physical activity 
interventions have been common strategies employed.  However, they have proved to be 
difficult for the general population (Rossmeisl e al., 2009).  Besides food restriction, 
nutritional approaches that show a potential in the prevention of weight-related diseases 
is the dietary consumption of ω3 PUFA, DHA and EPA, commonly found in fatty fish 
oils and -glucans primarily present in cereal grains such as barley and oats. 
Therefore, the main goals of the research discussed in this dissertation were to 1) 
investigate the effects feeding a fish oil-containing diet on nutrient digestibility, lipid and 
protein metabolism, postprandial glycemia, and body weight in mature overweight and 
young lean adult dogs and 2) determine the effects of incremental levels of barley; rich in 
-glucans a highly fermentable type of dietary fiber, on apparent nutrient digestibility, 
fecal quality and odor, postprandial glycemic and insulinemic responses, and plasma 
cholesterol levels in adult dogs. 
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CHAPTER 2: LITERATURE REVIEW 
 
Obesity is a pandemic problem, most prevalent in developed nations. In the U. S. 
approximately two thirds of the human population is either overweight or obese (WHO, 
2011; Hedley et al., 2004).  Obesity is defined as excess body fat accumulation that may 
impair health.  Subjects can be considered obese when their body mass index (BMI) 
exceeds or equals 30 kg/m2; BMI is a relationship between weight (in kilograms) and the 
square of height (in meters).  Overweight is considered a pre-obese stage where BMI is 
equal or superior to 25 kg/m2 (WHO, 2011).  Energy imbalance between calorie intake 
and expenditure is the main cause in the development of obesity.  The contemporary life-
style and the advancement in food processing technology may be the major contributors 
for the increase in the incidence of obesity.  The contemporary human population has a 
decreased physical activity due to more sedentary forms of work, combined with 
increased availability of highly palatable and energy-dense foods; high in fat and in 
processed and refined carbohydrates and sugars (WHO, 2011).  Medical co-morbidities 
associated with obesity or overweight are: hypertension, diabetes or insulin resistance, 
cardiovascular diseases, metabolic syndrome, musculoskeletal disorders (e.g., 
osteoarthritis and fractures), hyperlipidemia, and some cancers (American Cancer 
Society, 2011; American Heart Association, 2011; WHO, 2011; Allison et al., 1999).  
Along with the increased incidence of chronic diseases, a recent epidemiological study 
reported that life expectancy might be reduced by 6 to 7 y in obese subjects (Peeters et 
al., 2003). 
Similarly to humans, the incidence of obesity in the companion animal population 
has also skyrocketed and it has been considered the most common nutritional disorder in 
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pets (German, 2006).  Differently than in humans, dogs and cats are considered 
overweight when their body weight exceeds 15% of their ideal body weight and obese 
when their body weight surpasses 30% of optimal (Burkholder and Toll, 2000).  In 
parallel with increased obesity, higher manifestation of chronic diseases, similar to 
humans, have also being observed in veterinary clinics. 
The domestication of dogs and cats and more recently, their anthropomorphism, 
have drastically changed the environmental and social behavior of these animals.  During 
this process, dogs moved away from hunting, living in groups, and fighting for survival 
and reproduction for the maintenance of their species to live, mostly, indoors, 
individually housed or maybe with a companion dog; 62% of the household have only 
one dog (APPA, 2011) and the average of dogs owned per household is 1.7 (AVMA, 
2007), and with minimal reproduction purpose; 75% of the pet population is neutered 
(ASPCA, 2011).  All of these changes have contributed to the increased incidence of 
obesity in the pet population, mainly when combined with lack of exercise, overfeeding, 
or unbalanced diet (Jeusette et al., 2005). 
Common therapeutic options in the management or in the control of obesity have 
been: dietary management, mainly by energy restriction, and increased physical activity.  
Although conceptually well based, in practice they are not easily achieved by humans and 
consequently by pets, since they rely on the will of the owners.  Therefore, alternative 
strategies in the dietary management of obesity have included considerations about the 
nutrient composition of diets or use of supplements as a mean to aid in weight loss or 
avoid weight gain, as well as to ameliorate some of the chronic health problems related to 
obesity. Among them, 3 PUFA, namely docosahexanoic acid (DHA) and 
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eicosapentanoic acid (EPA), mainly found in fatty cold-water fish, and -glucans 
primarily present in cereal grains such as barley and oats have shown positive results.  
They have been effective in promoting weight loss or in preventing weight gain (Sato et 
al., 2007; Kunesová et al., 2006; Ruzickova et al., 2004; Baillie et al., 1999; Hainault et 
al. 1993), in lowering plasma cholesterol and triglycerides (Queenan et al., 2007; Kim 
and Choi., 2005; Mori et al., 1999; Anderson et al., 1990), in  improving glycemic 
response (Mello and Laaksonen, 2009; Ajiro et al., 2000; Feskens et al., 1991), or in 
enhancing protein metabolism (Hayashi et al., 1999; Selleck et al., 1994; Mendez et al., 
1992; Teo et al., 1989). 
This review will focus on the general processes related to the digestion, 
absorption and metabolism of dietary lipids and carbohydrates, as well as on specific 
nutraceutical effects related to the consumption of fish oil and barley; rich in ω3 PUFA 
and -glucans, respectively, in the management or prevention of canine obesity and other 
chronic diseases related to weight bearing. 
 
LIPIDS 
Digestion, absorption, and metabolism 
Lipids are organic compounds that are relatively insoluble in water but relatively 
soluble in organic solvents and serve important biochemical and physiological functions 
in plant and animal tissues.  In companion animal nutrition, lipid is an important dietary 
component since it serves many functions: concentrated energy supply, source of 
essential fatty acids, carrier of the fat-soluble vitamins, integral constituents of cell 
membranes, and enhancer of palatability and food texture (NRC, 2006; Pond et al., 
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1995).  The most important lipid constituents in animal nutrition include: fatty acids, 
mono-, di-, and triglycerides, and phospholipids.  Glycolipids, lipoproteins, and sterols 
are important in metabolism but are present in lower amounts in the body than 
triglycerides, the main form of energy storage in animal tissue (Pond et al., 1995). 
Dietary lipids are derived, primarily, from animal fat or seed oils.  Animal fats are 
predominantly comprised of saturated fatty acids ( 50%), which reflect de novo 
synthesis of fatty acids from dietary carbohydrates (Aldrich, 2005; NRC, 2006).  When 
animals are fed diets containing sources of unsaturated fatty acids, they can be 
incorporated into the animals’ fat tissue (Leskanich et al., 1997; Scollan et al., 2001), 
resulting in changes to the fatty acid profile of these tissues.  This is true for monogastric 
and ruminant animals, even though in the latter this process is less efficient due to the 
ruminal biohydrogenation of dietary fibers (Scollan et al., 2001).  Lipids from vegetable 
sources will have a more variable composition of fatty acids.  Seed oils can be rich in 3 
or 6 18-C fatty acids, and some may have varying amounts of both (NRC, 2006).  
Marine fat sources, e.g., fish and algae oils, are rich in 3 long-chain PUFA.  Because of 
their nutritional benefits, their use in companion animal diets has increased.  However, 
the high unsaturation of marine oils predisposes them to fat oxidation, challenging their 
use in pet food.  Therefore, fish oil is used in small amounts, approximately 1% (Aldrich, 
2006), while poultry, mammal fat or oil seeds comprise the predominant lipid sources in 
dietary formulation for dog and cat food. 
The majority of the dietary lipids are in the form of triglycerides.  In order to be 
absorbed, triglycerides need to be broken down into monoglycerides and free fatty acids.  
In some animal species, lipid digestion starts with the action of lingual lipase.  Dogs and 
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cats lack the activity of this enzyme (Iverson et al., 1991; Knospe and Plendl, 1997).  
Therefore, the first step in the hydrolysis of lipid in dogs and cats takes place in the 
stomach by the action of gastric lipase (Carriere et al., 1992; Knospe and Plendl, 1997).  
The lumen of the small intestine is the major site of lipid digestion.  Bile salts and 
pancreatic secretions are required for proper lipid digestion.  In dogs and cats, bile acids 
are conjugated with taurine and form the following bile salts: taurocholic acid, 
taurodeoxycholic acid, and taurochenodeoxycholic acid (NRC, 2006).  These bile salts 
emulsify the lipids into smaller fat droplets facilitating the activity of pancreatic lipase-
colipase complex (Borgstrom, 1975).  Pancreatic lipase hydrolyzes the ester bonds 
between the glycerol backbone and each fatty acid of triglycerides, yielding β-
monoglycerides and free fatty acids (from positions 1 and 3 of the triglyceride 
molecules).  Final solubilization of products of lipid digestion occurs through the action 
of bile salts (Pond et al., 1995).  The later will be responsible for the micelle formation.  
Micelles have an amphipathic property, once in contact with the brush border membrane 
of the enterocytes, micelles diffuse through the phospholipid bilayer membrane into the 
cells (Swenson and Reece, 1996). 
Fatty acid appropriate transport and absorption processes are compromised by 
their poor solubility in an aqueous environment (Vorum et al., 1992).  The capacity of 
lateral diffusion of fatty acids through the phospholipid bilayer of endothelial plasma 
membrane is too low to account for all the fatty acids taken up and metabolized by the 
body cells (Glatz and Van der Vusse, 1996).  This fatty acid demand relates to the 
intestinal uptake of dietary fatty acids, their storage in, and mobilization from, 
triacylglycerols in adipose cells, energy production from fatty acid oxidation, the 
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incorporation of fatty acids into complex lipids such as phospholipids and 
cholesterolesters, fatty acylation of specific proteins, and the function of fatty acids and 
metabolites as signaling compounds (Glatz and Van der Vusse, 1996).  Thus, a number of 
specific proteins have been identified which can reversibly and non-covalently bind fatty 
acids, greatly enhancing their aqueous solubility and thus facilitating their transport.  
Such proteins are generally considered to take part in both extracellular and intracellular 
fatty acid transport.  In blood plasma and interstitial fluid, albumin is the main carrier of 
fatty acids (Glatz and Van der Vusse, 1996). 
Short chain fatty acids and some medium chain fatty acids (up through C14) are 
absorbed directly into the blood via the intestinal capillaries and travel through the portal 
vein similarly to other nutrient absorptive processes.  Long chain fatty acids and some 
medium chain fatty acids, however, are too large to be directly released into the small 
intestinal capillaries.  Instead, in the enterocyte these fatty acids bind to fatty acid binding 
proteins that will carry them to endoplasmatic reticulum where they will be re-esterified 
back to triglycerides.  The triglycerides and cholesterol are coated by enterocyte-
produced apolipoprotein B48 into a compound called chylomicron (Bauer, 2004).  Within 
the villi, the chylomicra leave the enterocytes by reverse pinocytosis into lacteals (Pond 
et al., 1995); which merges into larger lymphatic vessels.  Chylomicra are transported via 
the lymphatic system and the thoracic duct, and are emptied by the thoracic duct into the 
bloodstream.  At this point the chylomicra can transport the triglycerides to where they 
are needed (Swenson and Reece, 1996). 
Because lipids are not soluble in water, their metabolism is mediated by plasma 
lipoproteins.  These molecules differ in size, density, and electrophoretic motility (Jones 
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and Manella, 1990).  Chylomicra and very low-density proteins (VLDL) are the largest 
and lighest classes of lipoproteins, whereas low-density lipoproteins (LDL) and high-
density lipoproteins are smaller and denser (Jones and Manella, 1990).  Chylomicra are 
responsible for the transport of dietary lipids from the small intestine.  Once these 
molecules enter the circulation, they acquire apo C and E peptides from HDLs, which 
determines their metabolic fate (Bauer, 2004).  Apo C peptides facilitate the delivery of 
triglycerides to adipose and muscle tissues working as a cofactor for lipoprotein lipase.  
This enzyme is present at the capillary endothelium wall and anchored by proteoglycan 
chains of heparin sulfate, not being found freely in the blood (Bauer, 2004).  In contrast, 
apo E peptide will remove chylomicron remnants from systemic circulation by binding 
with hepatic receptors (Hui et al., 1986). 
Differently than chylomicra, VLDL, HDL and LDL are, predominatly, 
responsible for the metabolism of endogenous lipids.  The VLDL are mainly synthesized 
in the liver and responsible for the transport of triglycerides during post-absorptive state. 
In the circulation, they also attain apo C and E peptides and therefore have similar 
metabolic fate as the chylomicra (Bauer, 2004).  Remnant particles of VLDL can be 
removed by the liver or be transformed to LDL (Jones and Manella, 1990).  The LDL are 
involved in the supply of cholesterol to extrahepatic tissues to be used in the synthesis of 
steroid hormones and cell membranes (Jones and Manella, 1990 and Brown and 
Goldstein, 1984); whereas HDL do the reverse cholesterol transport.  Dogs and cats have 
copious amounts of HDL.  They function as donors and acceptors of apo C, apo E and 
lipids from other lipoproteins.  Triglycerides brought back to the liver by HDL are 
hydrolyzed by hepatic lipase, whereas cholesterol ester will be secreted in the bile or 
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redistributed among lipoproteins (Bauer, 2004).  In humans, lecithin-cholesterol acyl 
transferase (LCAT) and cholesterol ester transfer protein (CETP) are involved in the 
reverse cholesterol transport.  However, in dogs and cats the activity of CETP has not 
been determined (Tsutsumi et al., 2001; Watson et al., 1995).  This difference in the HDL 
metabolism of dogs and cats might be responsible for lower susceptibility of these 
animals in developing atherosclerosis.  The enzyme CETP is responsible for the 
exchange between triglycerides from LDL and VLDL with cholesterol from HDL, and 
also the endocytosis of apo B-containing LDL and VLDL remnants.  Normally, the 
cholesterol present in these remnant molecules would be catabolized in the liver, however 
if the receptors are overwhelmed they may accumulate increasing the risk for 
atherosclerosis (Bauer, 2004). 
Similar to humans, obese dogs have higher predisposition to insulin resistance and 
hyperlipidemia, defined as supraphysiological levels of triglycerides, cholesterol, or both 
(Jeusette et al., 2005).  Omega 3 PUFA, DHA and EPA may alter lipid metabolism.  
Some of their beneficial effects on health have been: anti-atherogenic ability, decrease in 
plasma triglyceride and cholesterol concentrations, protective effect against weight again 
or promotion of weight loss, and reduction of chronic inflammatory processes.  All of 
which, are promising in the management and prevention of obesity and chronic diseases 
associated with it, as well as being a means to improve the life quality and longevity of 
the companion animals. 
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ESSENTIALITY AND NUTRACEUTICAL EFFECTS OF 3 PUFA 
In nutrition, the term “essential” refers to the inability or inefficiency of the body 
to synthesize a nutrient in adequate amount.  The fatty acids that belong to the 6 and 3 
families contain the first double bond between carbons 6 and 7, and 3 and 4 counting 
from their methyl end, respectively.  Because de novo desaturation of fatty acids occur 
from the carboxyl end by the activity of 9 desaturase, vertebrates, through de novo 
synthesis, can synthesize 9 fatty acids that are non-essential fatty acids.  Linoleic acid 
and -linolenic acid are members of the 6 and 3 fatty acid families, respectively, and 
they cannot be de novo synthesized.  Therefore, theybare considered essential for dogs 
and cats (NRC, 2006).  They also serve as the “parent” fatty acids of the 6 and 3 series 
fatty acids, which are competitively synthesized through several elongation and 
desaturation reactions.  The final products are arachidonic acid and docosahexaenoic acid 
(DHA).  The process of elongation and desaturation of 6 and 3 fatty acids from 
linoleic acid and -linolenic acid is not very efficient in dogs and cats due to limited 
activity of 6 desaturase (NRC, 2006).  Nonetheless, the products from this process have 
important physiological functions, and because of it, their longer-chain derivatives are 
considered “conditionally essential” in the nutrition of dogs and cats.  Good examples of 
conditionally essential nutrients are DHA and eicosapentanoic acid (EPA), both 3 fatty 
acids.  Currently, the recommendation for dietary supplementation for 6 and 3 fatty 
acids in diets for adult dogs is as follow: 9.5 g/ kg DM of linoleic acid, 0.36 g/ kg DM of 
-linolenic acid, and 0.44 g/kg DM of DHA plus EPA in diets with an energy density of 
4,000 kcal ME/ kg (NRC, 2006). 
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Mechanisms of 3 PUFA in the Treatment of Obesity and Metabolic Syndrome 
The anti-obesity property of 3 fatty acids has been attributed to their role in 
adipocyte hyperplasia (cell proliferation) and hypertrophy (cell enlargement; Azain, 
2004).  Fatty acids and their metabolites are ligands of peroxisome proliferator activated 
receptors (PPAR).  The stimulation of PPAR result in increased fatty acid oxidation 
(Kliewer et al., 1997).  Additionally, unsaturated fatty acids are potent inhibitors of 
hepatic lipogenesis by down regulation of fatty acid synthase enzyme (Azain, 2004).  
Prevention of adipocyte hypertrophy and hyperplasia has also been observed by increased 
activity of CPT-1 in several tissues (adipose, and cardiac and skeletal muscles), which 
increases fat oxidation, by increased activity of malonyl-CoA decarboxylase, which 
inhibits lipogenesis (Power et al., 1997), and by increased gene expression of PPAR- co-
activator 1 and nuclear respiratory factor-1; both are involved in mitochondrial 
biogenesis and oxidative metabolism (Flachs et al., 2005). 
Kunesová et al. (2006) reported that severely obese subjects supplemented with 
2.8g/d of 3 PUFA lost more weight than the control group.  This outcome was observed 
in conjunction with higher serum levels of -hydroxybutyrate (BHB), which was related 
to an up-regulation of -oxidation caused by the activation of hepatic PPAR (Kunesová 
et al., 2006). 
A well-documented effect of 3 PUFA is their hypolipidemic capability.  
However, the mechanism behind it has not been completely elucidated (Bays et al., 
2008).  Several mechanisms have been proposed, one of them suggests that EPA and 
DHA reduce triglyceride synthesis and enhance triglyceride plasma clearance (Ikeda et 
al., 2001; Agren et al., 1996).  The latter being potentially mediated by apolipoprotein E.  
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Hepatic lipogenesis is suppressed by down regulation of sterol regulatory element-
binding protein-1c (SREBP-1c) activity and by hepatic and muscular PPAR activation 
(Davidson, 2006).  Dietary supplementation of fish oil has been shown to decrease 
hepatic mRNA expression of SREBP-1c (Le Jossic-Corcos et al., 2005).  Omega 3 PUFA 
may inhibit the formation of the nuclear liver X receptor (LXR)  and retinol X receptor 
(RXR)  heterodimers and consequently their binding with the SREBP-1c promoter, 
which in turn leads to suppression of mRNA expression of SREBP-1c (Yoshikawa et al., 
2002). 
Another possible mechanism for the triglyceride-lowering effects of 3 PUFA 
relates to the up regulation of -oxidation; increasing fatty acid degradation, results in 
less fatty acids available for triglyceride and VLDL synthesis (Bays et al., 2008).  Rats 
fed an 3 PUFA - containing diet increased mitochondrial and peroxisomal -oxidation 
(Harris and Bulchandani, 2006).  Increased fat oxidation in the peroxisome may also 
explain some of the anti-obesity effect of 3 PUFA, because more energy will be lost as 
heat with lower ATP synthesis (Wanders, 2004).  In the study by Harris and Bulchandani 
(2006), rats fed the 3 PUFA diet also had lower activity of hepatic enzymes involved in 
the synthesis of triglycerides: phosphatidic acid phosphatase and diacylglycerol 
acyltransferase. 
Omega 3 PUFA also have hypocholesterolemic properties.  This 
hypocholesterolemic effect is achieved by inhibition of cholesterol synthesis.  
Polyunsaturated fatty acids are potent inhibitors of 3-hydroxy-3-methyl-glutaryl 
coenzyme A (HMG-CoA) reductase, which is important in the regulation of the rate 
limiting step in cholesterol synthesis: conversion of HMG-CoA to mevalonate 
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(Notarnicola et al., 2010).  Fish oil supplementation has been shown to decrease 
cholesterol levels in dogs (Pasquini et al., 2008; Wright-Rodgers et al., 2005) and in 
murine models (de Silva et al., 2004; le Morvan et al., 2002; Dallongeville et al., 2001). 
A less consistent nutraceutical effect of 3 PUFA is related to improvements in 
glycemic and insulinemic responses.  While evidence exists for the beneficial effects of 
their supplementation on the prevention and management of insulin resistance and 
glucose intolerance (Samane et al., 2009; Lombardo et al., 2006; Storlien et al., 1987), a 
few studies reported no health benefits (Gillam et al., 2009; Holness et al., 2004; 
Sasagawa et al., 2001).  Omega 3 PUFA may improve insulin sensitivity and glucose 
uptake by a PPAR-dependent mechanism (Poudyal et al., 2011).  Fish oil reduced 
phosphorylation of c-Jun N-terminal kinases (JNK), tau and insulin receptor substrate-1 
(IRS-1), which are normally high in diabetes or insulin resistance (Ma et al., 2009).  In 
addition, in liver and adipose tissues of mice fed fish oil, genes for GLUT2 and GLUT4, 
as well as IRS-1 and IRS-2 were up regulated (Gonzalez-Periz et al., 2009).  To our 
knowledge only one study has examined the effects of ω3 PUFA, DHA and EPA, on 
insulin sensitivity and glucose tolerance in healthy non-obese dogs (Irvine et al., 2002).  
Dietary 3 PUFA supplementation was not effective.  The authors suggested the animals 
were less responsive to the ω3 PUFA treatment because they were insulin sensitive. 
Omega 3 PUFA are important mediators of inflammatory processes; they 
suppress inflammation by production of anti-inflammatory metabolites or by competitive 
inhibition of the 6 fatty acid pathway and pro-inflammatory metabolites such as 
cytokines, series-2 prostaglandins and series-4 leukotrienes (Poudyal et al., 2011).  The 
anti-inflammatory effects of ω3 PUFA seem to be mediated by lipoxygenase and 
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cyclooxygenase, which generate series-3 prostaglandins and thromboxanes, and series-5 
leukotrienes (Larsson et al., 2004).  Recently, it was demonstrated that DHA and EPA are 
also involved in the formation of macrophage and inflammatory mediators such as: 
protectins, maresins, resolvins, and pro-resolvins (Serhan et al., 2009).  This effect 
comprises a novel mechanism by which DHA and EPA contribute to anti-inflammatory 
processes. 
In canine nutrition, supplementation of ω3 PUFA has shown positive effects in 
the control of osteo, renal and cardiac diseases (Fritsch et al., 2010; Brown et al., 1998; 
Freeman, 1998; Kang and Leaf, 1996), which can be partially attributed to the anti-
inflammatory properties of these fatty acids.  Supplementation of fish oil (27 mg/ kg BW 
of EPA and 18 mg/ kg BW DHA) for dogs suffering from congestive heart failure 
decreases the anti-inflammatory marker Il-1 and improves cardiac cachexia, which is 
characterized by a depletion of muscle mass (Freeman, 1998).  In another study, dietary 
supplementation of DHA and EPA demonstrated an antiarrhythmic effect in dogs with 
heart problems (Kang and Leaf, 1996).  While Brown et al. (1998) reported that 
nephrectomized dogs supplemented with fish oil (15% of dietary fat intake) had 
improved renal function, decreased proteinuria, serum cholesterol and triglyceride levels. 
Two recent studies evaluating the effects of ω3 PUFA in dogs suffering from 
osteoarthritis have reported that supplementation of fish oil (0.8% DHA and EPA) 
improved animals’ ability to rise from resting, positioning and their ability to walk 
(Roush et al., 2010a,b).  A third study, analyzing the effects of increasing dosages of fish 
oil in osteoarthritic dogs found supplementation of fish oil ω3 PUFA (2.94% DHA+EPA) 
to be effective in the improvement of lameness (Fritsch et al., 2010).  The previous 
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authors speculated that the beneficial effects observed by supplementation of fish oil ω3 
PUFA was due to their ability to suppress inflammation and to promote the synthesis of 
anti-inflammatory eicosanoids. 
 
CARBOHYDRATES 
Digestion, absorption, and metabolism 
Carbohydrates comprise up to 70% of the dry matter of plants, whereas in animal 
tissues, carbohydrates made up less than 1% of the weight of the animal, consisting 
mainly of glucose and glycogen (Pond et al., 1995).  In nutrition, carbohydrates are used 
as an energy source, however, like other animal species dogs and cats do not have a 
nutritional requirement for carbohydrates (Kettlehut et al., 1980 and Romsos et al., 1976).  
Under specific physiological conditions, for example gestation and lactation, scientific 
data exist showing that carbohydrate intake improves the animals’ performance by 
sparing other nutrients like protein and lipids from being used as energy sources (Romsos 
et al, 1981 and Kienzle et al., 1985).  In companion animal nutrition carbohydrates 
comprise 30-60% of the pet food formulations (Carciofi et al., 2008) but also are 
fundamental in the plasticity and gel-forming ability of extruded and canned products. 
Carbohydrates are very heterogeneous compounds; including low and high 
molecular weight sugars, starches, and structural polysaccharides (Bach-Knudsen, 1997).  
Their unique molecular arrangement: type of monomers and linkages among them, 
dictates their function in plants and in animals.  Dietary carbohydrates can be classified 
into four functional groups: absorbable, digestible, fermentable and non-fermentable 
(NRC, 2006).  Monosaccharides (glucose, fructose, and galactose) are considered 
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absorbable carbohydrates because they do not require hydrolytic digestion to be absorbed 
by the enterocytes.  Digestible carbohydrates are represented by non-structural 
saccharides that are hydrolytically digested by the animal.  Starch is probably the most 
common digestible carbohydrate present in human and animal diets along with low 
molecular weight sugars, such as lactose, maltose, and sucrose.  Carbohydrate fractions 
that escape hydrolytic/enzymatic digestion in the small intestine, also named dietary 
fibers, will enter the large intestine where they have the potential to be fermented by the 
hindgut microbiota.  Common fermentable carbohydrates are: resistant starches, 
oligosaccharides (e.g., stachyose, raffinose, fructooligosaccharides, 
mannanoligosaccharide, galactooligosaccharides, and lactulose), and certain 
polysaccharides (e.g., -glucans, pectins, gums, and hemicellulose).  Cellulose and lignin 
(a phenolic compound), are classic examples of non-fermentable dietary fibers (NRC, 
2006). 
In some monogastric species (e.g., humans and pigs), the digestion of 
carbohydrates starts in the mouth in the presence of salivary -amylase (ptyalin).  In the 
case of the dogs and cats, carbohydrate digestion takes place in the small intestine by the 
action of pancreatic -amylase (lumen) and disaccharidases (e.g. maltase, lactase, and 
sucrase) present in the brush border membrane.  In contrast to proteins and lipids, which 
can be absorbed as single amino acids and small peptides, or as free fatty acids and 
monoglycerides, respectively, carbohydrates have to be digested down to monomers 
(glucose, fructose, and galactose) in order to be absorbed in the small intestine. In the 
small intestine brush border membrane the absorptive process of monosaccharides is 
achieved mainly by apical membrane transporters such as: sodium glucose co-transporter 
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(SGLT-1) and a family of glucose transporters (GLUT2, GLUT5).  Through SGLT-1 
glucose and galactose can be actively absorbed while fructose is absorbed by the 
facilitated transporter GLUT5.  During the post-prandial period the concentration of 
monosaccharides may saturate SGLT-1 and GLUT5.  The transporter GLUT2 can be 
translocated to the apical membrane of the enterocyte to aid in the facilitated absorption 
of glucose and fructose (Kellet et al., 2008; Helliwell and Kellet, 2002; Kellet and 
Helliwell, 2000).  Once in the enterocytes, glucose, galactose and fructose are transported 
out of the enterocyte through GLUT2 in the basolateral membrane.  These 
monosaccharides then diffuse in a concentration gradient into capillary blood and into the 
portal circulation towards the liver. 
Glucose plays a major rule in the mammalian metabolism.  Once absorbed, 
glucose enters the blood pool being distributed among the body tissues.  In order to be 
metabolized, glucose will be phosphorylated to glucose-6-phosphate, which is a key 
intermediate for many metabolic pathways.  In a post-prandial state glucose may have 
several metabolic fates: it can be used in glycogenesis mainly in the liver and at some 
extent in skeletal and cardiac muscle to form glycogen; it can also enter glycolysis and it 
can be converted to pyruvate that in turn enters the citric acid cycle or lipogenesis.  
Glucose-6-phosphate can be oxidized in the pentose phosphate cycle, generating reducing 
equivalents (NADPH) and ribose-5-phosphate important for synthesis of nucleotides and 
nucleic acids. 
Fructose and galactose are metabolized predominantly in the liver.  They are first 
phosphorylated by fructokinase and galactokinase, respectively, and through a series of 
metabolic steps will be converted to pyruvate that then can enter the citric acid cycle, be 
19 
used in the synthesis of fatty acids (as previously discussed for glucose), or as substrates 
for glycogen synthesis. 
Most carbohydrate sources are not completely digested by hydrolytic and 
enzymatic process.  Therefore, di, oligo and polysaccharides that resisted the digestion at 
the small intestine will enter in the large intestine where they may be fermented by 
enteric bacteria.  Degradation of these compounds will result in the formation of short 
chain fatty acids (SCFA), mainly, acetate, propionate and butyrate, whereas non-
fermentable fibers will be excreted in feces.  The absorption of SCFA across the 
intestinal mucosa has been shown to occur through the nonionic diffusion of protonated 
SCFA and through a carrier-mediated anion exchange (Charney et al., 1998; Cook and 
Sellin, 1998).  More recently, Gill et al. (2005) have proposed a new mechanism in the 
absorption of SCFA by a family of monocarboxylate transporters (MCT).  In this model, 
MCT1 is responsible for mediating the SCFA from the intestinal lumen into the 
colonocytes, while MCT4 and MCT5 are present in the basolateral membrane and 
facilitate the exit of the SCFA from the colonocytes into the portal circulation (Gill et al., 
2005). 
A primary role of SCFA is to be used as an energy source by the colonic mucosa, 
meeting approximately 60-70% of the energy requirement of these cells. In this matter, 
butyrate is the preferred substrate being followed by propionate and acetate (Wong et al., 
2006).  Acetate is the predominant SCFA being produced by fermentative processes in 
the hindgut, succeeded by propionate and butyrate (Englyst et al., 1987).  Acetate is also 
involved in cholesterol and fatty acid synthesis and serves as energy fuel for many 
tissues, particularly the cardiac muscle during fasting periods (Wong et al., 2006).  
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Proprionate is a precursor of glucose through gluconeogenesis, but also inhibits 
cholesterol synthesis in rats and pigs (Hamer et al., 2008; Illman et al., 1988; Boila et al., 
1981).  Butyrate is extensively metabolized by colonic epithelia and therefore little of it 
reaches the liver (Cummings, 1991).  Similarly to acetate, butyrate can be used as a 
substrate for fatty acid synthesis or as a precursor for the citric acid cycle. Along with 
SCFA other gases: methane (CH4), hydrogen sulfide (H2S), and carbon dioxide (CO2) are 
formed during fermentation. 
In addition to the production of SCFA, dietary fibers play an important role in gut 
health and in the management of some pathological conditions.  Fermentable and soluble 
fibers increase digesta viscosity, decrease gastric emptying, increase satiety, reduce the 
rate of glucose uptake, lower blood cholesterol levels, and promote growth of gut 
commensal bacteria (Jenkins et al., 2008; Brennan and Cleary, 2005; Tungland, 2003; 
German et al., 1996).  Conversely, non-fermentable and insoluble fibers decrease gastric 
transit time, increases fecal bulk and moisture, and aid in laxation (Wenk, 2001). 
 
BARLEY AND THE ROLE OF BETA-GLUCANS IN NUTRITION 
Traditionally in companion animal nutrition, corn and rice have been probably the 
most popular ingredients used as sources of carbohydrates (mainly starch), while beet 
pulp has been considered the gold standard as a dietary fiber source.  Because of the 
increased awareness of the beneficial effects of dietary fibers in health, as well as the 
popularity of holistic and natural diets, novel carbohydrates have become widespread in 
human and pet nutrition.  Consequently, cereal grains with low-glycemic index (defined 
as a lower glycemic response as a percent of the response of a standard carbohydrate 
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source, e.g., glucose or white bread) and rich in fermentable and soluble (viscous) fibers 
such as; barley (Hordeum vulgare) and oats (Avena sativa) have received increasing 
interest. 
Cereal β-glucans are classified as soluble dietary fibers and have rheological 
properties similar to guar gum and other random coil polysaccharides (Wood, 2007).  On 
average, the β-glucan content in oats and barley ranges between 3-7% and 5-11%, 
respectively (Skendi et al., 2003) and is a prevalent component of the cell wall of these 
cereal grains (Wood, 2007).  The molecular arrangement of β-glucans consists of D-
glucose molecules connected by a series of β- (1→3) and β- (1→4) linkages (Queenan et 
al., 2007).  The viscous behavior of these non-starch polysaccharides is related to their 
physical entanglements; the presence of β- (1→3) linkages leads to bends in the straight 
chain of the polymer allowing water to permeate and conferring the high water solubility 
and viscosity of β-glucans (Vasanthan and Temelli, 2008; Guillon and Champ, 2003). 
The beneficial physiological effects related to the consumption of β-glucans have 
been associated with their capacity to form high viscous solutions (Wood, 2007).  A 
previous study (Wood et al., 1994) demonstrated that the viscosity of β-glucans accounts 
for 79-96% of the changes in glycemic and insulinemic responses.  Additional factors 
that influence the bioactivity of β-glucans are: the molecular weight (MW) and 
concentration, the nature of the extract, the form of delivery, and the dose ingested.  
Viscosity increases exponentially with concentration and MW.  Biorklund et al. (2005) 
reported that oat β-glucan with a MW of 70,000 lowered serum cholesterol and 
postprandial glucose and insulin levels, whereas barley β-glucan with a lower MW of 
40,000 did not.  In addition, it has been suggested that the use of an intact food as a 
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source of β-glucans as oppose to the use of a more purified form can interfere in their 
behavior (Wood, 2007).  It has also been proposed that bioactivity of β-glucans may be 
increased when they are consumed with a meal, instead of between meals (Wolever et al., 
1994), and that their ingestion as a drink is more effective than when incorporated into 
food matrixes (Kerckhoffs et al., 2003).  According to FDA (2005), a daily intake of 3g 
of barley or oat β-glucans may have positive effects on health.  Dose response studies 
have reported a direct relationship between amount of β-glucans consumed and health 
improvements (Cavallero et al., 2002; Davidson et al., 1991).  Furthermore, rheological 
properties of β-glucans can be modified by thermal treatment; cooking and freezing 
processes may decrease their solubility (Anderson et al., 2004; Beer et al., 1997).  This 
effect on solubility cannot be overlooked by the pet food manufacturers because of the 
harsh thermal treatments (e.g., extrusion and canning) applied in their products that may 
decrease the bioactivity of β-glucans.  In addition to intrinsic characteristics of cereal β-
glucans, the physiological responses observed after their ingestion can also be driven by 
other factors.  They may include: age, gender, and physiological status of the subjects 
consuming them (Ripsin et al., 1992). 
 
β-glucans and Nutrient Digestibility 
Cereal β-glucans affect several aspects of the digestive process: site and extent of 
digestion (Wilfart et al., 2007 and Bach Knudsen and Hansen, 1991), enzymatic activity 
(Hedemann et al., 2006), nutrient absorption (Bach Knudsen et al., 2000), and systemic 
and gastrointestinal hormonal responses (Ellis et al., 1995; Serena et al., 2009).  Results 
from animal studies, have shown controversial effects of dietary β-glucan in nutrient 
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digestibility and absorption, as well as in animal performance.  In studies using swine, 
dietary β-glucan decreased nutrient digestibility and absorption, as well as growth 
performance (Bach Knudsen et al., 2000; Back Knudsen et al., 1993), while others have 
found positive or no detrimental effects of supplementation of β-glucan on nutrient 
digestibility and performance (Renteria-Flores et al., 2008; Hahn et al., 2006; Fortin et 
al., 2003; Jensen et al., 1998). 
To our knowledge, literature available about the effect of cereal β-glucans on 
nutrient digestibility in dogs is practically nonexistent.  The only study found on this 
topic reported that inclusion of 40% of extruded barley to a basal diet, predominantly 
made of corn, wheat, and animal fat, resulted in decreased fecal dry matter and 
consequently looser stools.  Calculated barley nutrient digestibility was high for organic 
matter (92%, OM) and for nitrogen free extract (98%, NFE), whereas crude protein (CP) 
digestibility was lower being reported as 71% (Groner and Pfeffer, 1997).  Lower 
apparent CP digestibility in dogs fed diets containing soluble dietary fibers has been 
attributed to an increased fecal excretion of microbial mass, due to increased fermentative 
process in the large intestine (Middelbos et al., 2007). 
Few other mechanisms have been proposed in order to explain how β-glucans 
may positively or negatively impact nutrient digestibility and absorption.  Improvements 
in nutrient digestibility could result from delayed gastric emptying rate and longer mean 
retention times induced by increased viscosity of the digesta.  This long retention time 
would extend the contact of the nutrients in the gastrointestinal tract with digestive 
enzymes (Owusu-Asiedu et al., 2006; Bray 2002; Schneeman, 1998) or could be a 
reflection of a greater digestibility of dietary fiber due to the fermentation of β-glucans 
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(Le Goff and Noblet, 2001).  Conversely, decreased nutrient digestibility and absorption 
could indicate reduced digestive enzyme activity by non-specific binding of the enzymes 
or presence of specific enzyme inhibitors (Dunaif and Schneeman, 1981). 
 
β-glucans in the Management of Obesity and Chronic Diseases 
In human trials, consumption of cereal β-glucan improved glycemic response 
(Jenkins et al., 2008; Panahi et al., 2007).  Likewise, dietary β-glucan decreased insulin 
responses in healthy humans (Juvonen et al., 2009; Nazare et al., 2009), and in obese and 
type II diabetic patients (Kim et al., 2009; Liatis et al., 2009).  In contrast, other studies 
have failed to detect improvements in insulin response by the dietary supplementation of 
β-glucan using human (Frank et al., 2004) and animal models (Bach Knudsen et al., 
2000; Bach Knudsen et al., 2005).  Insulin is quickly cleared in the liver and this may 
impact variability and accuracy of its measurements.  C-peptide is produced by the 
pancreas in an equimolar ratio with proinsulin and because it has a lower hepatic 
clearance rate, and renal excretion, when compared to insulin (Polonsky and Rubenstein, 
1984), it may be an alternative for use in the evaluation of insulinemic responses. 
The effect of β-glucan in blunting glycemic response is possibly mediated by the 
delay in gastric emptying, resulting in slower and gradual absorption of glucose (Lo et 
al., 2006).  This mechanism may also postpone the feeling of hunger caused by a rapid 
decrease in blood glucose (Ludwig, 2003).  Beta-glucans have also been implicated in 
increasing phosphatidylinositol 3-kinases and protein kinase (PI3K/ Akt) activity (Chen 
and Seviour, 2007).  In insulin sensitive subjects, insulin binds with its receptor and 
activates the intracellular subunit tyrosine kinase domain, which initiates a cascade 
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response, activating IRS- proteins that will activate PI3K/Akt pathway.  However, insulin 
resistant or diabetic subjects have compromised ability in insulin signaling due to 
diminished insulin-induced tyrosine phosphorylation of IRS-proteins, which impairs the 
PI 3-kinase/Akt activation and thereby the translocation of GLUT4 to the surface of 
muscle and fat cells (Asano et al., 2007). 
Because insulin also mediates fatty acid uptake in muscle cells, subjects with 
insulin resistance or diabetes will have higher levels of circulating free fatty acids, which 
will result in increased triglyceride synthesis and assembly of VLDL (Hobbs, 2006).  The 
proposed mechanism by which β-glucan aids in the control of hyperlipidemia is by 
adhering with bile acids present in the gastrointestinal tract, increasing their elimination 
in feces, and as a consequence LDL will be utilized in the hepatocytes as substrate for 
bile acid synthesis (Nilsson et al., 2007).  An alternative mechanism that may also 
contribute in the hypocholesterolemic effect of β-glucans is the increased production of 
SCFA by fermentative process, mainly propionate that suppresses hepatic cholesterol 
synthesis (Wright et al., 1990). 
OVERALL OBJECTIVES 
 The hypothesis of the research project was that dietary supplementation of fish oil 
or barley would be well tolerated by adult dogs, resulting in no detrimental effects on 
nutrient digestibility.  In addition, these ingredients would attenuate postprandial 
glycemic responses, as well as blood lipid metabolites (e.g., triglycerides, cholesterol, 
HDL and LDL).  Therefore, the experiments presented in this dissertation were designed 
with the following objectives: 
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1. To determine the effect of feeding a fish oil-containing diet on nutrient 
digestibility, lipid and protein metabolism, postprandial glycemia, and body 
weight in mature overweight dogs. 
2. To verify the effect of feeding a fish oil-containing diet on nutrient digestibility, 
lipid and protein metabolism, postprandial glycemia, and body weight in adult 
lean dogs. 
3. To examine the effects of incremental levels of barley; rich in -glucans a highly 
fermentable type of dietary fiber, on apparent nutrient digestibility, fecal quality 
and odor, postprandial glycemic and insulinemic responses, and plasma 
cholesterol levels in adult dogs. 
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CHAPTER 3: INFLUENCE OF FEEDING A FISH OIL CONTAINING DIET TO 
MATURE OVERWEIGHT DOGS: EFFECTS ON LIPID METABOLITES, 
POSTPRANDIAL GLYCEMIA, AND BODY WEIGHT 
 
INTRODUCTION 
Currently, there are more than 77.5 million pet dogs in the United States and 93.6 
million pet cats, and nearly 62% of the households have at least one pet (APPA, 2011).  
In 1995, the prevalence of obesity in US dogs was around 34% (Lund et al., 2006).  A 
recent study by the Association for Pet Obesity Prevention (APOP) found that 
approximately 55% of dogs and 53% of cats were overweight or obese (Calabash, 2011), 
which demonstrates that the population of obese and overweight dogs continues to 
increase.  Obesity has become the most common form of malnutrition in dogs in the 
United States (Case et al., 2000) and the most prevalent nutritional disorder encountered 
in small animal medicine (Jeusette et al., 2005a). 
The high incidence of obesity in the pet population can be attributed to several 
factors including; genetic predisposition, sedentarism, neutering and spaying practices, 
ingestion of highly palatable and energy-dense foods.  Similar to humans, obese pets are 
more prone to be affected by weight-related diseases such as diabetes mellitus, 
hyperlipidemia, arthritis, and kidney disease.  In order to aid in the control of pet obesity, 
common management strategies have been adopted: energy restriction, increased exercise 
activity, or a combination of the two.  Problems observed with these strategies have 
included exacerbated behavioral stress and lower compliance of pet owners (Mitsuhashi 
et al., 2010).  Because of the low success rate of these management strategies, more 
attention has been given to the nutrient composition of diets.  Scientific evidence suggests 
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that different carbohydrate and lipid sources can aid in weight loss.  Among them 3- 
PUFA, docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA) mainly found in 
fatty fish oil, have shown positive results on weight loss in obese women and in rats 
(Kunesova et al., 2006; Sato et al., 2007).  Additionally, interactions between dietary 
lipids, proteins and carbohydrates on attenuation of plasma glucose and insulin 
concentrations, as well as body weight loss have been observed (Collene et al., 2005; 
Gentilcore et al., 2006; Gunnarsson et al., 2006; Sato et al., 2007).  Mechanisms involved 
in the positive outcomes with fish oil consumption and the interactions between fat and 
protein sources with carbohydrates are not completely understood.  Additionally, most of 
the research conducted in this area has been performed using rodents as the experimental 
model and these findings may not always reflect canine metabolism.  Thus, the objective 
of this study was to determine the effect of feeding a fish oil-containing diet on lipid and 
protein metabolism, postprandial glycemia, and body weight in mature overweight dogs. 
 
MATERIALS & METHODS 
Animals and Model 
All animal care procedures were conducted under a research protocol approved by 
the Institutional Animal Care and Use Committee, University of Kentucky, Lexington.  
Seven purpose-bred mature female dogs (Marshall Bioresources, North Rose, NY), with 
an average age of 9 years, and initial BW of approximately 27 ± 1.3 kg were used in the 
experiment.  Dogs were randomly divided into two groups, and each group was randomly 
assigned to one of two diets, control (CO) or fish oil (FO), in a cross-over design.  There 
were two experimental periods and each was 69 days in length.  Experimental periods 
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were separated by a wash out period of 30 days to minimize carry-over effects.  The dogs 
were individually housed in kennels (1 x 1.5 m) with a slotted floor in a temperature-
controlled room with a light: dark cycle of 12 hours at the Division of Laboratory Animal 
Research Facility at the University of Kentucky.  Each kennel was connected to a 
concrete outside run (1 x 2 m) where animals had free diurnal access.  Dogs were also 
allowed to exercise and to have social interaction in outside and/ or inside play areas for 
an average of 3 hours daily, except during urine and fecal collection periods.  During 
nitrogen balance collections, dogs were confined to the indoor portion of their kennels for 
a period of 6 days, and human interaction was provided for a minimum of 20 minutes per 
dog daily.  For urine collection following glucose tolerance tests animals were confined 
to the indoor portion of their kennels until the next morning. 
 
Treatments and Feeding 
 Two dry, extruded kibbled diets were used.  All diets were formulated to be 
isonitrogenous and isocaloric.  Diets had similar ingredient compositions and nutrient 
profiles (Tables 3.1 and 3.2, respectively), except that for source of oil.  This replacement 
led to alterations in the fatty acid profile of these diets (Table 3.2).  Diets were formulated 
in accordance with the Association of American Feed Control Officials (2002) nutrient 
guide for dogs and balanced to meet maintenance requirements. 
Prior to the start of the experiment the dogs were fed ad libitum (Canine Active 
Diet Hills Science Diet, Topeka, KS), a high fat (28%), high protein (30%) diet to ensure 
that the animals would increase their body weight to 20% over ideal body weight (based 
on each dog’s records for the previous year). The 20% increase body weight aimed a 
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body condition score (BCS) of approximately 7, which is described as: ribs palpable with 
difficulty; heavy fat cover, with noticeable fat deposits over lumbar area and base of tail, 
and with waist absent or barely visible, whereas the ideal body weight was considered a 
BCS=5 (ribs palpable without excess fat covering, with waist observed behind ribs when 
viewed from above and abdomen tucked up).  Larson et al. (2003) suggested that 
approximately 20% body fat was the critical point at which dogs became insulin resistant.  
At the beginning of each experimental period dogs were gradually transitioned onto 
experimental diets over a five day period.  During the experiment the dogs were fed to 
maintain their increased BW, which was established at the beginning of each 
experimental period.  Energy requirements were calculated using the formula, 100kcal 
ME * kgBW 0.75 (Gross et al., 2000).  Dogs were fed twice a day, at 0630 and 1830 in 
stainless steel bowls.  All dogs were allowed 20 minutes to consume the food.  Any 
remaining orts were collected, weighed, and recorded.  Water was available ad libitum 
throughout the experiment.  On the days when a glucose tolerance test was performed, 
animals were not fed in the morning, and their daily ration was offered at the afternoon 
feeding time. 
 
Experimental Procedures 
Blood Sampling 
Venous blood samples (8 mL) were collected on d 0, 30, 60 and 69 via jugular 
puncture into a sodium heparin containing vacutainer (Becton Dickson, Franklin Lakes, 
NJ), and placed on ice for plasma glucose, triglycerides, total cholesterol, HDL, LDL, -
hydroxybutyrate (BHB), non-esterified fatty acids (NEFA), insulin, glucagon, ghrelin, 
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and lipoprotein lipase (LPL) determination.  Blood samples were kept on ice and 
centrifuged at 4,000 x g for 15 min at 4C to collect plasma.  Plasma samples were stored 
at -20C until analysis. 
 
Glucose Tolerance Test 
Glucose tolerance tests were performed at the beginning of the experiment to 
establish baseline values (prior to treatment), and at 30 and 60 days of feeding the 
experimental diets.  Prior to the test, animals were fasted overnight and the next morning 
the area over the cephalic vein was prepared by clipping hair and disinfecting with 
alcohol and an i.v. catheter (20Gx 1 ¼) was placed in the cephalic vein and secured with 
tape and an injection cap and filled with heparinized saline (20 units/mL) to ensure 
patency.  The dogs were infused with a 500 g/L solution (Hospira Inc., Lake Forest, IL) 
of D-glucose (2g/kg body weight) through the intravenous catheter (Larson et al., 2003).  
After D-glucose infusion, blood samples (4mL) were collected via intravenous catheter at 
5, 10, 15, 30, 45, 60, 90, 120, 150 and 180 min counted from the starting time of glucose 
infusion.  Between sampling times, a heparin solution (20 units of heparin per mL) was 
infused to prevent blood from clotting in the catheters.  Once blood sampling was 
completed, catheters were removed and animals received their daily amount of food.  
Blood and plasma samples were processed and stored in a similar manner as described 
for baseline samples. 
Concomitantly with the glucose tolerance test, urine was collected for 
approximately 20 h after D-glucose infusion (1230 and 0630 on the next morning) to 
monitor glucose loss via urine.  Urine was collected via catch pans that were 
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approximately 1 x 1.5 m.  These pans were made of stainless steel and had one inch 
raised edges on three sides, with a flat edge on one of the 1m sides.  The pans were 
placed under the slotted floor of the kennels and suspended by wire at the back of the 
kennels so that they were sloping towards the front of the kennel.  Fiberglass screens with 
stainless steel frames were placed on the top of each pan to keep hair and feces out of the 
urine.  A watertight, plastic trough was placed under the front edge of the pan to collect 
the excreted urine.  Eight milliliters of 6 N H3PO4 was added into the plastic troughs at 
the time of placement in order to acidify and preserve the urine. 
 
Nitrogen Balance and Protein Turnover 
Sampling periods began at 0630 on day 63 of each experimental period, when 
dogs entered confinement, and ended at 0630 on day 69.  Dogs were weighed prior and at 
end of collection periods. 
 Total urine was collected at 0630, 1230 and, 1830 daily during the collection 
period.  Urine was collected using the system described above.  Eight mL of 6 N H3PO4 
was put into the plastic troughs at placement.  The urine catch pan was rinsed down with 
water three times daily (0630, 1230 and, 1830) during the sampling period to ensure 
complete collection.  Each rinse was approximately 80 mL spread evenly over the entire 
pan.  Total urine collected for each individual dog was placed into a tared plastic 
container.  Fifty percent of the total urine collected from a 24 hour period was 
composited for each dog within experimental period and frozen. 
Just before the 0630 feeding on day 66 of each period a single dose (7.5 mg/kg) of 
15N-glycine (Andover, MA, Cambridge Isotope Laboratories, Inc.) was administered 
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orally to each dog via a gelatin capsule (Size 000, Park City, UT, Nutraceutical Corp.).  
From day 66 at 0630 through day 69 at 0630 25% of acidified urine from each dog was 
separated, composited and frozen for later analysis for 15N-glycine enrichment.  Total 
feces were collected at the same intervals, by removing fecal matter from the slotted floor 
of the kennels as well as from the fiberglass screen on top of the urine catch pan.  After 
collection, feces were weighed, placed in labeled plastic bags and frozen until analysis.  
At the end of each collection period fecal samples were composited by animal. 
 
Blood Metabolite Analyses 
Plasma glucose, triglycerides, total cholesterol, and HDL concentrations were 
analyzed by Konelab 20 XTi, using available commercial kits (Infinity, Thermo 
Electron Corporation, Louisville, CO).  Low density lipoprotein (LDL) concentration 
were determined similarly to the methodology above using an enzymatic method; LDL 
Cholesterol Reagent (Thermo Electron Corporation, Pittsburg, PA).  Plasma NEFA was 
assayed using an enzymatic method (Wako NEFA C kit, Wako Diagnostics, Richmond, 
VA, USA).  Plasma BHB was analyzed by enzymatic method (LiquiColor Reagent Kit, 
Stanbio Laboratory, Boerne, TX, USA). 
Aliquots of plasma were collected, and analyzed for plasma insulin, glucagon, 
ghrelin, and lipoprotein lipase (LPL) concentrations as described previously (Yamka et 
al., 2006). 
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Feed, Fecal and Urine Sample Analyses 
Samples from the two test diets were collected throughout the experimental 
periods and stored at -20˚C until chemical analyses were conducted.  Diet samples were 
ground in a Wiley mill (model 4, Thomas Swedesboro, NJ) through a 2-mm screen.  Each 
diet was analyzed for dry matter (AOAC, 2000), crude protein; calculated from total N 
values (Vario Max CN, Elementar, Hanau, Germany), total dietary fiber (Prosky et al., 
1992), gross energy using an oxygen bomb calorimeter (model 1756, Parr Instruments, 
Moline, IL) and fat content; measured by acid hydrolysis (AACC, 1983) followed by 
ether extraction (Budde, 1952).  Fatty acid profile of experimental diets was analyzed as 
described previously (Fritsch et al., 2010). 
Fecal samples were composited for each dog, within period and homogenized.  
Similarly to the diets, feces samples were analyzed for DM, CP and fat content.  
Approximately, 1 g samples of wet feces were dried in a 105°C circulating air oven 
overnight, and difference in weight was used to determine absolute dry matter.  
Approximately 500 mg of wet feces were weighed into crucibles and analyzed as is for 
nitrogen content.  Dried (55°C) ground fecal samples were used to determine fecal fat 
content as described above.  Urine composites were thawed, homogenized and 1 g 
aliquots were weighed into crucibles containing 100 mg of steel wool and 200 mg of 
sucrose to determine nitrogen content.  Urea and 15N nitrogen enrichment contents in 
urine composites prior and post 15N-glycine dosing were analyzed as previously 
described by Reeder et al. (2011).  All samples were analyzed in duplicate with a 5% 
error allowed between duplicates; otherwise, analyses were repeated. 
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Calculations 
Glucose Tolerance Test 
Incremental area under the curve (IAUC) for plasma glucose was calculated 
according to method of Wolever et al. (1991) using GraphPad Prism 5 Software 
(GraphPad Software, Inc., San Diego, CA).  Peak area for plasma glucose was also 
calculated using GraphPad Prism 5 Software (GraphPad Software, Inc., San Diego, CA).  
This software calculates the area under the curve using the trapezoid rule.  It permits the 
separation of the data into different regions as a fraction of the total area and to calculate 
the highest point of each region (peak).  Glucose fractional clearance rate, k, was 
calculated as the slope of the line of natural log glucose concentration against time 
between 5 and 90 min following glucose i.v. administration.  Half life, which is the time 
required for glucose concentration to fall by half, was estimated between 5 and 90 min 
postinfusion, using the formula (Kaneko et al., 2008): 
 
T1/2 = 0.693 x 100 = minutes,  
               k 
 
Zeroed plasma glucose concentration at peak (5min) was calculated as: 
Zglu= [glucose] at 5 min postinfusion – [glucose] at baseline (preinfusion) 
The zero correction is important to remove variation from differing plasma glucose 
baseline concentrations and to facilitate comparisons of glucose concentration post 
infusion on a similar scale and the incremental response based on glucose concentration 
at baseline. 
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Fraction of glucose in urine was calculated using the formula: 
GLUfrac (%)= 100- ቀሺୢୣ୶୲୰୭ୱୣ ୢ୭ୱୣ,୫୥ሻି ሺ୥୪୳ୡ୭ୱୣ ୣ୶ୡ୰ୣ୲ୣୢ ୧୬ ୳୰୧୬ୣ,୫୥ሻୢୣ୶୲୰୭ୱୣ ୢ୭ୱୣ,୫୥ ቁ x 100 
 
Nitrogen Balance 
All nitrogen balance calculations were done on a dry matter (DM) basis.  Nitrogen 
from feed was considered nitrogen intake, while nitrogen from urine composites and 
feces were nitrogen outputs.  Apparent nitrogen absorption (NA), nitrogen retention 
(NR), %DM digestibility, and apparent %nitrogen (N) digestibility were calculated, with 
all values on a g/d basis, as: 
NA (g/d) = (N from intake – N from feces) 
NR (g/d) = N absorbed – N from urine 
% DM digestibility = (DM intake – DM output) *100 
                                                (DM intake) 
 
% N digestibility = (N intake – N from feces) *100 
                                                    (N intake) 
 
% N balance = (N intake – (N from feces + N urine) *100 
                                                    (N intake) 
 
 
 Whole body protein turnover was measured using the 15N-glycine single-dose 
urea end-product method (Waterlow et al., 1978).  This procedure assumes that 15N-
glycine will be partitioned mainly between protein synthesis and oxidation in the same 
proportion as total amino acid turnover, and that oxidized end products are excreted 
quantitatively in the urine.  Therefore, by measuring the amount of 15N-glycine not 
incorporated into body tissues, protein turnover (g N/d) can be calculated (Wessels et al., 
1997).  Whole body protein turnover was calculated as: 
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Q = d/G 
where Q represents protein turnover (g N/d), and d is the rate of urea N excretion (g/d) 
from day 66 1230 through day 69 at 0630.  The samples from day 66 0630 were not 
included since they represented urine that was excreted before the 15N-glycine dose was 
administered.  In the equation, G represents the fractional recovery of 15N from 15N-
glycine in urine urea.  The 15N enrichment of all urine samples was corrected for 
background 15N enrichment (Wessels et al., 1997).  From whole body protein turnover, 
protein synthesis (PS) and protein degradation (PD) were calculated using the following 
equations: 
PS (g N/d) = [Q – (N excreted in urine)] 
PD (g N/d) = [Q – (N intake – N in feces)] 
where N excreted in urine, N intake, and N in feces were all represented on a (g N/day) 
basis. 
 
Statistical Analysis 
Data from glucose tolerance test, lipid and blood metabolites were analyzed as 
repeated measurements in a cross-over design using the Mixed procedure of SAS (SAS 
Inst., Inc., Cary, NC).  All other variables were analyzed by the Mixed procedure of SAS 
(SAS Inst., Inc., Cary, NC).  The statistical model included the fixed effect of treatment, 
and the random effects of period and animal.  All treatment least squares means were 
compared to each other and Tukey adjustment was used to control for experiment wise 
error.  Plasma β-hydroxybutyrate, ghrelin, and glucagon data were not normally 
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distributed, so a log transformation was applied for analysis.  Differences between means 
with P<0.05 were considered significant and means with P0.10 were considered trends. 
 
RESULTS 
Glucose Tolerance Test 
Incremental area under the curve (IAUC), peak area and zeroed glucose 
concentration at peak (Table 3.3) did not differ between treatments or among sampling 
days within treatment.  A tendency for a day x treatment interaction was noted for 
glucose half life (p<0.10), which was decreased in the FO treatment on d30 when 
compared to its baseline value (d0).  In contrast, half life was not affected by the control 
diet.  Only a day effect was observed for glucose fractional clearance rate (p=0.0073); d 
30 and 60 differed from baseline.  The fraction of dextrose in urine did not differ between 
dietary treatments or among sampling days within treatment.  Similarities of baseline 
values between CO and FO treatments suggest that the wash out period (30d) was 
adequate to remove any potential carry over effect of dietary treatments.  No body weight 
change was observed during the experiment. 
 
Blood metabolites 
β-hydroxybutyrate, NEFA and triglycerides (Table 3.4) did not differ between 
treatments or among sampling days within treatment.  There was a treatment x day 
interaction for fasting plasma cholesterol concentration (p=0.0002).  Cholesterol did not 
differ in the CO treatment, however, it was decreased (p<0.05) in the FO treatment on 
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d30, d60 and d69 when compared to baseline (d0).  Similarly, a treatment x day 
interaction (p=0.0051) was observed for high density lipoprotein (HDL).  While it did not 
differ in the CO treatment, HDL was decreased in the FO treatment on d69 when 
compared to baseline (d0).  For the low density lipoprotein (LDL) there was a treatment 
and day effect.  The FO treatment LDL was lower than the CO treatment.  A treatment 
effect was also observed for plasma ghrelin; the FO group was higher than the CO group 
(p= 0.0036).  There were no treatment effect seen for fasting plasma glucose, insulin, 
glucagon, or LPL concentrations (P>0.05). 
 
Nutrient Digestibility, Nitrogen Balance and Protein Turnover 
Feed refusals were minimal and nutrient intakes were similar between treatments 
(Table 3.5).  Fecal excretion, dry matter and fat digestibilities were not affected by 
treatment.  Similarly, nitrogen intake, fecal and urine N excretion, N absorbed, N 
digestibility, N retained, and N balance did not differ between the treatments (Table 3.6).  
In addition, there was no change in body weight during the nitrogen balance periods in 
both treatments.  Protein turnover, synthesis and degradation were similar in dogs fed the 
CO and the FO diets. 
 
DISCUSSION 
Previous research has demonstrated health benefits associated with the 
consumption of fish oils, particularly those rich in DHA and EPA.  These ω3 fatty acids 
have been related to lower plasma triglyceride (Kim and Choi., 2005), to promote weight 
loss (Kunesova et al., 2006; Sato et al., 2007), and to improve glycemic response (Ajiro 
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et al., 2000 and Feskens et al., 1991).  However, most of the research conducted in this 
area has been performed using murine and human models and these findings may not 
always translate to the canine.  Additionally, obesity is an increasing concern in the pet 
population and fish oil may be an effective strategy to attenuate problems related to this 
metabolic syndrome.  Therefore, the objective of this study was to determine the effect of 
feeding a fish oil containing diet on lipid and protein metabolism, postprandial glycemia, 
and body weight in mature overweight dogs. 
 
Glucose Tolerance Test 
In this study, the intravenous glucose tolerance test was used to assess the dogs’ 
ability to utilize glucose and as an indirect means to assess insulin sensitivity in these 
animals.  In dogs, it has been demonstrated that basal insulin level increases with age and 
that fat mass is positively correlated with glucose peak and incremental increase after 
IVGTT (Larson et al., 2003).  In the latter study, senior dogs fed at maintenance had 
increased glucose half life of approximately 43% in comparison to energy-restricted 
leaner dogs; suggesting that a threshold of 20% fat mass existed at which the dogs 
became less insulin sensitive (Larson et al., 2003).  Therefore, the mature overweight 
model utilized in this experiment was expected to show signs of insulin resistance, which 
could have been depicted by increased glucose IAUC as well as longer glucose half-life 
and lower glucose clearance rate.  The dogs had fasting plasma insulin levels above the 
normal physiological range suggesting that they were insulin resistant and therefore, a 
valid model to test our hypothesis. In support of our results and use of the experimental 
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model, similar glucose half life values, 26.2 and 27 ± 14 min, have been reported for 
overweight or obese senior dogs (Verkest et al., 2011; Larson et al., 2003). 
In this study, it was also anticipated that dietary supplementation of FO would 
alleviate or resolve some of the problems related to glucose utilization and metabolism.  
However, after a maximal challenge with infusion of 2 g/ kg BW glucose (Larson et al., 
2003) the CO and FO treatments had similar glucose IAUC, peak area, zeroed glucose at 
peak and fractional clearance rate.  A similar peak plasma glucose concentration (3 min), 
51 ± 4 mmol/L, has been reported for obese dogs during i.v. administration of glucose at 
a dose of 1g/ kg of body weight (Verkest et al., 2011).  In the current study, a decrease of 
11.5% of glucose half-life on d 30 in the FO treatment was observed and it tended to 
differ from its baseline value, indicating that the dogs fed the FO diet improved their 
ability to clear glucose following a glucose tolerance test, probably by an increased 
sensitivity to insulin signaling. 
In support of our results, similar glucose clearance rate of 2.5 %/min has been 
noted in non-obese dogs supplemented with ω3 PUFA (Irvine et al., 2002).  Evidence 
exists for the beneficial effects of ω3 PUFA supplementation on the prevention and 
management of insulin resistance and glucose intolerance (Samane et al., 2009; 
Lombardo et al., 2006; Storlien et al., 1987).  However, this topic is still controversial 
because a few studies reported no health benefits (Gillam et al., 2009; Holness et al., 
2004; Sasagawa et al., 2001).  To our knowledge only one study has examined the effects 
of ω3 PUFA, DHA and EPA, on insulin sensitivity and glucose tolerance in healthy non-
obese dogs (Irvine et al., 2002).  The authors found the supplementation to not be 
effective.  They suggested the animals were less responsive to the ω3 PUFA treatment 
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because they were insulin sensitive.  In the current study, the reason for the lack of 
response to dietary FO supplementation is unclear.  Factors that might have contributed 
are the large animal variation in response to IVGTT, the low power (n=7), the need for a 
longer treatment period, and the FO dose. 
Two recent studies evaluating the effects of ω3 PUFA in dogs suffering from 
osteoarthritis have reported that similar doses to the one utilized in the current study 
(around 0.8% DHA and EPA) improved weight bearing (Roush et al., 2010a,b).  A third 
study, analyzing the effects of increasing dosages of FO in osteoarthritic dogs found that 
a higher dose of FO ω3 PUFA (2.94% DHA+EPA) to be more effective in the 
improvement of weight bearing and lameness (Fritsch et al., 2010).  In contrast to our 
study, the aforesaid studies had a larger number of dogs per treatment, ranging from 22 
up to 71, and longer experimental periods, varying from 90 to 168 d. 
 
Blood metabolites 
Total CHOL values in the present study were similar to literature values reported 
for dogs over 6y of age (Pasquini et al., 2008).  In addition, a previous study (Jeusette et 
al., 2005a) demonstrated that morbid obese dogs have increased total plasma CHOL 
concentration compared to lean controls or obese dogs maintained at a low energy 
intakes.  Both studies support our results and appear to be good comparisons to our 
findings because of the similarities with the animals’ physiological status (age or body 
condition) and species used as the experimental models. 
Physiological serum CHOL concentration for healthy dogs ranges from 3.6-5.4 
mmol/L (Jones and Manella, 1990), therefore the dogs utilized in this study presented 
43 
signs of hypercholesterolemia.  In contrast to humans, hypercholesterolemia in dogs does 
not increase the incidence of atherosclerosis mainly due to differences in the lipoprotein 
metabolism such as; predominant HDL fraction and absence of the enzyme cholesteryl 
ester transfer protein (Xenoulis and Steiner, 2010; McAlister et al., 1996; Jones and 
Manella, 1990).  Canine hyperlipidemia, however, has been related to pancreatitis, liver 
and ocular diseases, seizures, and increased morbidity (Xenoulis and Steiner, 2010; Jones 
and Manella, 1990).  Low fat diets have been employed to control hyperlipidemia in 
dogs; and fish oil supplementation has been suggested as an alternative dietary approach.  
In the current study, fasting plasma CHOL concentration in the FO treatment was 
decreased throughout the experiment when compared to its baseline value.  Plasma 
CHOL concentration in the FO group was closer to normal physiological levels, 
indicating that FO supplementation ameliorated hypercholesterolemia in these dogs.  
Likewise, lower cholesterol levels were observed in response to fish oil supplementation 
during maintenance in healthy lean dogs (Pasquini et al., 2008), as well as during 
gestation, lactation and perinatal period in dogs (Wright-Rodgers et al., 2005).  In 
contrast to FO, the CO group maintained a steady cholesterol concentration during the 
entire experiment. 
The lipoprotein fractions, HDL and LDL, in healthy dogs have been reported to 
range from 2.5-5.2 mmol/L and 0.49-2.25 mmol/L, respectively (Pasquini et al., 2008; 
Jeusette et al., 2005a; and Downs et al., 1997).  The mean HDL and LDL values for the 
current study were 5.31 and 0.32 mmol/L respectively for the CO and 5.04 and 0.28 
mmol/L respectively for the FO treatments.  Previously it has been shown that obese 
female Beagles have higher plasma HDL and LDL (5.77 and 0.78 mmol/L) 
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concentrations compared to lean controls (3.88 and 0.49 mmol/L) or obese energy-
restricted dogs (4.63 and 0.36 mmol/L) (Jeusette et al., 2005a).  In contrast, Bailhache et 
al. (2003) reported lower levels of plasma HDL cholesterol in obese male Beagles and no 
change in the LDL fraction.  The reason for the discrepancy between these two studies is 
not clear, but it could be related to differences in the experimental design, for example, 
the nutrient composition of the diet, the daily energy intake and the gender of the 
animals. 
Pasquini et al. (2008) and Barrie et al. (1993) reported that female dogs had 
higher plasma HDL cholesterol concentration than male dogs.  From our results, HDL 
plasma concentration falls within the range reported in the literature, whereas LDL 
plasma concentration is below the lowest values reported. Differences in methodology 
assaying LDL concentration could be a possible explanation for the lower levels of LDL 
observed in the current study; other studies have used fast-protein liquid chromatography 
(Bailhache et al., 2003) and ultracentrifugation and precipitation methods to determine 
LDL concentration, in contrast to the enzymatic method used in this study.  The latter 
could be not as efficient in detecting LDL or in separating the lipoprotein fractions, 
leading to an underestimation of LDL plasma concentration.  Additionally, the LDL 
fraction is normally low in dogs in relation to the HDL1 fraction, which is the 
predominant HDL fraction.  The LDL and HDL1 lipoproteins also have similar molecular 
size and hydrated density in dogs (Bauer, 2004), which could also played a role in the 
accuracy of the assay method. 
Supplementation with FO resulted in a numerically lower HDL concentration, but 
on d 69 it was decreased by 20% in relation to its baseline value.  Similar lipid lowering 
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effects were observed in response to FO supplementation in dogs (Pasquini et al., 2008; 
Wright-Rodgers et al., 2005) and in murine models (de Silva et al., 2004; le Morvan et 
al., 2002; Dallongeville et al., 2001).  In these studies, the period of exposure to the test 
diets varied substantially, anywhere from 1 wk (Dallongeville et al., 2001) up to 16 wks 
(le Morvan et al., 2002).  In the study by Wright-Rodgers et al. (2005), the lipid lowering 
effects of supplementation of FO were observed during gestation and lactation periods in 
female dogs, which corresponded to supplementation periods of 56 and 28 d, 
respectively.  Controversial results have been found on the effects of FO supplementation 
on plasma LDL concentration.  Dietary supplementation of FO has shown to increase 
LDL concentration in hamsters (de Silva et al., 2004).  In contrast, in this study LDL was 
decreased in the FO treated dogs, which agrees with other studies using the canine model 
(Pasquini et al., 2008; Wright-Rodgers et al., 2005). 
It is important to acknowledge that other studies have found no beneficial effect 
with supplementation of FO or 3 fatty acids, DHA and EPA, in lowering total CHOL 
levels in several experimental models (Fakhrzadeh et al., 2010; Mori et al., 1999; 
Dunstan et al., 1997; Goh et al., 1997; McAllister et al., 1996).  The most remarkable and 
consistent effect of FO supplementation on lipid metabolism has been in decreasing 
triglycerides (Mori et al., 1999; Lombardo et al, 1996; Williams et al., 1992), mainly in 
hypertriglycerimic models (Skulas Ray et al., 2011; Harris et al., 1997; Singer et al., 
1985).  In this experiment, fasting plasma TRIG concentration was greater (1.0 and 0.93 
mmol/L for the CO and FO treatment, respectively) than literature values (0.6 ± 0.3 
mmol/L) for healthy dogs (Pasquini et al., 2008 and Jones and Manella, 1990).  However, 
higher levels of TRIG have been reported in chronically and grossly obese dogs, 1.04 ± 
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0.15 mmol/L (Jeusette et al., 2005a).  The latter finding supports our results and seems a 
more appropriate data to be compared with, since the animal model used in current study 
was the mature overweight dog.  Even though, the plasma TRIG concentration was 
increased, it was still within the normal physiological range and no signs of 
hyperlipidemia were observed in these animals.  McAlister et al. (1996) did not find a 
TRIG-lowering effect after FO supplementation in dogs; the authors attributed the lack of 
response to the treatment to be associated with the normally low plasma levels of TRIG 
in dogs, which in their opinion made it harder to detect significant treatment differences.  
In addition, the TRIG-lowering capacity of fish oil and 3 fatty acids seems to be dose 
dependent.  Reduced serum TRIG concentration has been reported in studies with daily 
3 fatty acid supplementation of 3-4 g (Harris, 1999; Mori et al., 1999).  Utilization of 
such high doses of 3 fatty acids in dog food may pose a challenge for the pet food 
industry due to the high susceptibility of fish oil to fat oxidation and the need of extended 
shelf-life for its products.  It is also important to emphasize that TRIG response to 
supplementation of 3 fatty acids varies among species.  Studies using Rhesus monkey 
and swine models found no effect of fish oil in serum TRIG concentration (Davis et al., 
1987; Weiner et al, 1986).  Therefore, caution must be taken in doing extrapolations 
among experimental models, as they may not be appropriate.  Future studies looking at 
the ideal dose of fish oil to lower triglyceride levels in the canine model are needed. 
It has been suggested that obesity leads to insulin resistance, which results in 
increased plasma concentration of BHB and NEFA by stimulation of adipose tissue 
lipolysis (Rand et al., 2003; Leong and Wilding, 1999; Hall et al., 1984).  In the current 
study, mean plasma BHB and NEFA concentrations were similar to NEFA values 
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reported in adult lean dogs; 0.570.07 mmol/L (Jeusette et al. 2005a) and BHB reference 
ranges for dogs; 0.02-0.15 mmol/L (Duarte et al., 2002).  These findings suggest that 
insulin resistance did not occur in the canine mature overweight model utilized herein.  
Supplementation of FO did not lead to differences in plasma BHB or NEFA 
concentrations.  It differs from studies by Kunesová et al. (2006) and Murata et al. (2002) 
that found significantly higher serum BHB concentration in severely obese women 
supplemented with 3 PUFA and in Male Sprague-Dawley rats fed a FO-containing diet.  
However, Kunesová et al. (2006) observed no differences in serum NEFA levels between 
the control and 3 PUFA groups.  Fish oil has been implicated to increase ketogenesis 
and hepatic -oxidation by activation of peroxisome proliferator activate receptor alpha 
(PPAR).  It has also been suggested a potential synergistic effect of fish oil (or 3 
PUFA) supplementation in conjunction with dietary caloric restriction in obese subjects 
(Kunesová et al., 2006).  It is unclear the reasons for the lack of response to FO 
supplementation in the present study, since its dietary supplementation has been 
beneficial in obese and lean models.  Supplementation of fish oil or 3 PUFA, DHA and 
EPA, is expected to stimulate LPL activity in adipose and muscle tissues due to increased 
sensitivity to insulin.  Because of the non-invasive nature of this study, tissue biopsies 
(muscle and adipose) were not taken; therefore fasting plasma LPL concentration was 
measured as an attempt to detect dietary treatment effects on lipid metabolism.  In the 
present study, there were no differences in plasma LPL concentration between dietary 
treatments or among sampling days within treatment.  It’s important to recognize, 
however, that plasma LPL concentration may not reflect local regulation and activity of 
this enzyme in muscle and adipose tissues.  In agreement with our findings, few studies 
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demonstrated that FO supplementation did not influence plasma LPL activity in humans 
(Nozaki et al., 1991; Harris et al., 1988), whereas others found FO supplementation to be 
effective in increasing plasma LPL activity (Rudkowska et al., 2010; Harris et al., 1997; 
Kasim-Karakas et al., 1995). 
In obese humans, rodents and dogs suppressed levels of fasting plasma ghrelin 
have been indicated (Jeusette et al., 2005a,b; Ariyasu et al., 2002, Shiiya et a., 2002; 
Tschop et al., 2001).  To our knowledge, few studies have been published looking at 
plasma ghrelin levels in dogs (Bosch et a., 2009; Jeusette et al., 2005a,b) and none has 
investigated the effects of the supplementation of FO or its 3 PUFA in this species.  In 
this experiment, fasting plasma ghrelin concentration is in agreement with the canine 
literature that shows that obese dogs have lower plasma ghrelin than lean ones (Jeusette 
et al., 2005a,b).  From our results, dogs fed the FO diet had a 30% increase in plasma 
ghrelin concentration when compared to the CO group.  In support of our results, energy- 
restricted young overweight female subjects supplemented with DHA and EPA had 
increased plasma ghrelin concentration compared to the control group (Ramel et al., 
2009).  In the latter, the increase in plasma ghrelin was partially explained by weight loss 
and gender, and was associated with a decrease in fasting plasma insulin, which contrasts 
to our results where no difference in fasting plasma insulin or body weight was observed.  
The authors speculate that, in this study, the higher levels of plasma ghrelin in dogs fed 
the FO-containing diet may reflect a change in body composition; decreased fat mass and 
increased lean mass, potentially mediated by an improvement in insulin sensitivity.  Dogs 
on FO diet tended to have lower glucose half-life (d 30) after a glucose tolerance test, 
which matched with the highest level of plasma ghrelin.  However, fasting insulin 
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concentration was numerically higher in the FO treatment and body composition was not 
determined in this experiment. 
Excessive body fat is considered a risk factor for the development of diabetes type 
2, which is characterized by insulin resistance and beta cell dysfunction, and by 
hyperglucagonemia during fasting and lack of glucagon suppression following oral 
glucose and exaggerated glucagon responses to mixed meal ingestion (Unger and Orci, 
1981) due to a suggested reduced glucose sensitivity and/or insulin resistance in diabetic 
alpha pancreatic cells (Bagger et al., 2011).  In this experiment, a mature overweight 
canine model was used and it was hypothesized that these animals would have higher 
fasting glucagon concentrations.  It was also expected that the animals on the FO 
treatment would have lower fasting glucagon concentrations when compared to the CO 
treatment.  Fasting plasma glucagon concentrations of, approximately, 90 and 56 pg/ml 
have been reported for alloxan-diabetic and healthy dogs, respectively (Sakurai et al., 
1974).  Even though dietary treatment did not affect mean glucagon values in this study, 
numerically higher mean glucagon levels were noticed for the CO treatment when 
compared to the FO treatment.  The fasting plasma glucagon concentrations observed 
herein are above the values reported for healthy dogs, which may be suggestive of a 
decreased sensitivity to insulin.  Fasting plasma insulin concentrations were also 
increased in these dogs.  Serum insulin concentration for normal and obese type 2 
diabetic dogs range between; 5-20 U/ ml (or 6-24 pg/ml) and 20-130 U/ ml (or 24-155 
pg/ml), respectively (Kaneko, 2008).  The fasting insulin values in the current study were 
at least 3, up to almost 5 times, greater than the maximum value mentioned above.  No 
effect of FO supplementation was observed in fasting plasma glucagon and insulin levels.  
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Despite their elevated concentrations, fasting plasma glucose levels were within normal 
physiological range for healthy adult dogs, 3.6-6.5 mmol/L (Kaneko, 2008) and there was 
no dietary treatment effect.  In this study, the remarkably increased levels of fasting 
plasma insulin and glucagon suggest the presence of insulin resistance in these animals, 
and the euglycemic values observed could be a consequence of a compensatory secretion 
of pancreatic insulin, as it has been suggested by Verkest et al. (2011). 
 
Nutrient Digestibility, Nitrogen Balance and Protein Turnover 
Food intake did not differ between dietary treatments as the inclusion of 2% of 
fish oil in the diet matrix was not expected to result in food refusals.  Fecal excretion, N 
intake, DM and N digestibilities were also similar between the dietary treatments. 
Similarly, fat digestibility was not different between dietary treatments and as expected 
was high; 95.8 and 95.9% for the CO and FO diets, respectively. Dogs are well designed 
to digest and assimilate high amounts of dietary fat (Case et al., 2000).  Omega-3 fatty 
acids from fish oil, mainly DHA and EPA, have been shown to improve protein 
metabolism and to have a protein sparing effect in catabolic illness (Hayashi et al., 1999; 
Selleck et al., 1994; Mendez et al., 1992; Teo et al., 1989; DeMichele et al., 1988; Trocki 
et al 1987; Alexander et al., 1986).  Aging animals have increased bodily catabolic and 
inflammatory processes, thus it was expected that the FO diet would ameliorate such 
processes in mature overweight dogs.  However, in the current study, N metabolism, 
protein turnover, protein synthesis and degradation were not affected by the FO 
containing diet.  Discrepancies between the current study and the literature cited above 
could be related to differences in experimental design.  In this study, the mature 
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overweight model represented chronic inflammatory and catabolic processes, in contrast 
to the murine models that were young lean animals that were exposed to acute 
inflammatory and catabolic processes created by burn injuries (Selleck et al., 1994; 
Hayashi et al., 1999; DeMichele et al., 1988) or by injections of tumor cells (Mendez et 
al., 1992).  In addition, previous studies differed in the form of FO administration; 
parenteral (Hayashi et al., 1999; Mendez et al., 1992) or enteral nutrition (Selleck et al., 
1994; Teo et al., 1989; DeMichele et al., 1988) and in the dosage of FO provided.  Body 
weight did not differ between treatments.  This finding contradicts some of the literature 
that has found fish oil to be effective in weight loss treatment in obese humans 
(Kunesova et al., 2006; Thorsdottir et al., 2007), and in mice (Flachs et al., 2006; 
Ruzickova et al., 2004).  Although fish oil has been shown to be beneficial in weight loss, 
the data still not conclusive and few studies have found no significant effect using mouse 
and rat models (Gaiva et al., 2001; Takahashi and Ide, 2000; Hun et al., 1999;).  Overall, 
it seems that FO supplementation may aid in the glucose clearance rate in mature 
overweight dogs.  In addition, the FO lipid-lowering effects observed can be of help in 
the management of hyperlipidemia in dogs.  It also may pose an important tool for the pet 
food industry in developing diets for breeds predisposed to this disease or to obese dogs 
that are more prone to suffer from lipid metabolism abnormalities.  Pet owners have 
become increasingly aware of nutritional strategies to improve the health of their 
companion animals; nutraceutical effects of dietary supplementation of fish oil may 
become a determinant factor in the selection of food by pet owners.  Further studies in 
this area, however, are needed to advance and to verify our findings. 
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Table 3. 1.  Ingredient composition of control (CO) and fish oil (FO) diets fed to mature 
overweight dogs. 
  Treatment 
CO FO 
Ingredients, % as fed basis   
Rice, Brewers   43.70 43.70 
Corn-Starch      22.60 22.60 
Poultry Meal 13.80 13.80 
Poultry Fat   7.60 7.60 
Corn Gluten Meal     4.50 4.50 
Soybean oil    2.00 -- 
Fish Oil -- 2.00 
Cellulose    2.00 2.00 
Potassium Chloride     1.00 1.00 
Palatability Enhancer 1.00 1.00 
Dicalcium Phosphate 0.71 0.71 
L-Lysine  0.40 0.40 
Salt, Iodized    0.25 0.25 
Choline Chloride     0.17 0.17 
Calcium Carbonate   0.10 0.10 
Vitamin mix 0.10 0.10 
Mineral Mix a 0.05 0.05 
Magnesium Oxide    0.03 0.03 
a Formulated to supply at least (g/kg of food): 0.6 Mg, 1.8 Na, 7.0 K, 7.6 Cl, (mg/kg of 
food) 211 Fe, 163 Zn, 13 Cu, 13 Mn, 0.4 Se, 1.5 I (IU/g of food) 18.2 Vitamin A, 1.0 
Vitamin D, 0.18 Vitamin E (mg/kg of food) 0.3 Biotin, 1484 Choline, 1.9 Folic acid, 62 
Niacin, 18 Pantothenic acid, 8.6 Pyridoxine, 8.0 Riboflavin, 41 Thiamin, and 0.13 
Vitamin B12 
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Table 3. 2.  Chemical composition of control (CO) and fish oil (FO) diets fed to mature 
overweight dogs. 
 
  Treatment 
CO FO 
Item     
DM, % 92.40 92.80 
%, DM basis 
Acid hydrolyzed fat 14.70 14.33 
Total dietary fiber 5.1 5.3 
Crude protein  19.3 18.7 
Ash 4.06 3.95 
Gross energy, kcal/kg 4,608 4,584 
C18:0 Octadecanoic (Stearic) 1.40 1.32 
C18:1 Octadecenoic (Oleic) 5.23 4.81 
C18:2 Octadecadienoic Omega 6 3.29 2.00 
C18:3 Octadecatrienoic Omega 3 0.19 0.10 
C18:4 Octadecatetraenoic Omega 3 < 0.01 0.06 
C20:0 Eicosanoic (Arachidic) 0.03 0.03 
C20:2 Eicosadienoic Omega 6 0.06 0.06 
C20:3 Eicosatrienoic Omega 3 0.01 0.01 
C20:4 Eicosatetraenoic Omega 6 0.06 0.09 
C20:5 Eicosapentaenoic Omega 3 0.02 0.39 
C21:5 Heneicosapentaenoic Omega 3 < 0.01 0.01 
C22:2 Docosadienoic Omega 6 < 0.01 < 0.01 
C22:3 Docosatrienoic Omega 3 < 0.01 < 0.01 
C22:4 Docosatetraenoic Omega 6 0.02 0.02 
C22:5 Docosapentaenoic Omega 3 0.01 0.04 
C22:6 Docosahexaenoic Omega 3 0.01 0.25 
Total Omega 3 0.24 0.86 
Total Omega 6 3.47 2.21 
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Table 3. 3.  Glucose response to intravenous glucose tolerance test in mature overweight dogs consuming soy (CO) or fish oil 
(FO) containing diet. 
Treatment 
CO FO 
d0 d30 d60 d0 d30 d60 SEM 
Item 
Incremental area under the curve (0-180 
min), (min•mmol)/L 1422 1354 1317 1353 1338 1351 141.5 
Peak area 1388 1331 1278 1288 1292 1324 157.2 
Fractional clearance rate,  %/min 2.7 2.7 2.9 2.6 2.9 2.8 0.12 
Half life, min 26.1 25.4 23.6 26.6 23.6† 24.5  1.09 
Zeroed glucose concentration at peak, mM 51.2 50.5 52.1 49.3 60.0 55.1 4.90 
Urine glucose excretion, mM 514.3 383.6 415.2 413.6 492.5 402.3 62.17 
Fraction of dextrose dose in urine, % 16.7 14.7 14.0 15.0 14.4 13.2 1.23 
Body weight, kg 27.2 26.6 26.3 27.8 27.3 27.0 1.39 
† Tendency (P<0.10) to differ from its baseline value (d 0). SEM=pooled SEM, n=7 
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Table 3. 4. Fasting plasma lipid metabolites, lipoprotein lipase (LPL), ghrelin, glucagon, insulin, and glucose in mature 
overweight dogs consuming soy (CO) or fish oil (FO) containing diet. 
  Treatment 
CO FO 
d0 d30 d60 d69 d0 d30 d60 d69 SEM 
Item, mM   
Cholesterol* 5.95abc 5.89abcd 5.96abc 6.05ab 6.28a 5.41cd 5.33d 5.49bcd 0.231 
HDL* 5.12ab 5.38ab 5.33ab 5.39ab 5.63a 4.91ab 4.98ab 4.61b 0.282 
LDL** 0.33 0.31 0.30 0.30 0.32 0.26 0.24 0.25 0.029 
Triglycerides 0.98 0.95 1.03 0.84 0.82 0.80 0.81 0.70 0.150 
Non esterified fatty acids 0.73 0.44 0.54 0.42 0.60 0.46 0.55 0.46 0.092 
-Hydroxybutyrate1  0.048 0.054 0.047 0.043 0.053 0.048 0.045 0.044 0.0076
          
LPL, ng/ml 74.7 79.7 67.2 74.5 76.0 74.3 74.7 74.9 5.31 
Ghrelin, ng/ml1** 1.7 1.4 1.4 1.5 1.8 2.3 1.6 2.0 0.14 
Glucagon, pg/ml1 72.1 77.3 80.3 79.2 56.2 55.4 69.0 85.6 25.49 
Insulin, pg/ml 436.1 482.4 392.0 557.5 511.8 621.3 504.8 631.6 87.94 
Glucose,  mM 5.5 5.4 5.4 5.2 5.7 5.4 5.2 5.1 0.15 
  a-d Means in the same row not sharing common superscript letters are different (P<0.05). SEM=pooled SEM, n=7 
* Day x treatment interaction (p<0.05).  
** Treatment effect (p<0.05). 
1 Mean BHB, ghrelin and glucagon values reported are from not transformed data. 
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Table 3. 5.  Food intake (DM), fecal excretion, dry matter and fat digestibility in dogs 
consuming soy (CO) or fish oil (FO) containing diet. 
 Treatments     
Item CO FO SEM P- value1 
Food Intake (g DM/d) 291.9 287.7 13.54 0.7712 
Fecal Excretion (g DM/d) 28.42 28.32 1.749 0.9476 
DM Digestibility (%) 90.22 90.12 0.446 0.8372 
Fat Digestibility (%) 96.80 96.53 0.447 0.5470 
1 Main treatment effect. SEM=pooled SEM, n=7. 
 
 
 
 
 
Table 3. 6.  Nitrogen metabolism in dogs administered 15N – glycine and body weight 
change of dogs fed control (CO) and fish oil (FO) diets. 
Treatments    
Item CO FO SEM P-value1 
Food N Intake, g/d 9.00 8.60 0.406 0.3532 
Fecal N Excretion , g/d 1.59 1.62 0.072 0.6791 
Urine N Excretion, g/d 4.84 4.78 0.490 0.9404 
 
N Absorbed, g/d 7.41 6.97 0.426 0.2914 
N Digestibility, % 82.26 81.22 0.864 0.2753 
N Retained, g/d 2.58 2.20 0.523 0.6141 
N balance, % 28.63 24.74 5.709 0.6386 
     
Protein turnover (g N/d) 18.53 17.02 1.545 0.3656 
Protein synthesis (g N/d) 13.56 12.73 2.037 0.7010 
Protein degradation (g N/d) 11.11 10.03 1.274 0.5001 
 
Body weight change, kg -0.03 -0.17 0.082 0.2431 
1 Main treatment effect. SEM=pooled SEM, n=7. 
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CHAPTER 4: INFLUENCE OF FEEDING A FISH OIL CONTAINING DIET TO 
ADULT YOUNG LEAN DOGS: EFFECTS ON LIPID METABOLITES, 
POSTPRANDIAL GLYCEMIA, AND BODY WEIGHT 
 
INTRODUCTION 
Obesity is a serious health concern, as it continues to increase worldwide in 
human and companion animal populations.  According to the National Center for Disease 
Control and Prevention (CDC), 33.8% of the adult population in United States is obese 
(CDC, 2011).  Similarly, a recent study by the Association for Pet Obesity Prevention 
(APOP) found that approximately 21% of dogs and 32% of cats were obese (Calabash, 
2011).  Annually, human obesity costs 150 billion dollars for the US government (CDC, 
2011), and Veterinary Pet Insurance claims are over 14 million dollars for weight-related 
health problems (Ward, 2010). 
Besides the high medical cost the biggest problem faced with obesity is the higher 
incidence of morbidity and mortality due to increased predisposition of overweight and 
obese subjects to develop chronic diseases (e.g. insulin resistance, diabetes mellitus, heart 
disease, osteoarthritis, cancer, etc.).  A life-long study in dogs has shown that lean 
animals had a lifespan of about 1.8y longer than dogs with increased body fat mass 
(Kealy et al., 2002). 
Because obesity is the leading health threat in pets and the major cause of death in 
humans (Ward, 2010; CDC, 2010), many programs have been developed to increase 
awareness and prevention.  Nutritional and physical activity interventions have been 
common strategies employed, however they have proved to be difficult for the general 
population (Rossmeisl e al., 2009).  Besides food restriction, a nutritional approach that 
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shows a potential in the prevention of weight-related diseases is the dietary consumption 
of ω3 PUFA, DHA and EPA, commonly found in fatty fish oils (Rossmeisl et al., 2009; 
Storlien et al., 1987). 
Besides the antiobesity properties of ω3 PUFA (DHA and EPA), they also exhibit 
hypolipidemic and antidiabetic effects in murine and human models (Kim and Choi., 
2005; Mori et al., 1999; Ruzickova et al., 2004; Baillie et al., 1999; Hainault et al. 1993).  
In addition, enteral supplementation of fish oil in crossbred steers has been shown to 
increase amino acid and glucose disposal by improvement in muscle insulin sensitivity 
(Gingras et al., 2007).  Maintenance of muscle mass can be a valuable strategy in aiding 
in the control of obesity, since muscle mass partially defines the body’s basal metabolic 
rate (Gingras et al., 2007). 
Despite the potential health benefits observed with fish oil intake, the mode of 
action of the ω3 PUFA found in fish oil (DHA and EPA), as well as their interaction with 
protein and carbohydrate metabolism is not completely comprehended.  Moreover, the 
majority of the literature available in this topic was performed using murine models and 
these findings may not always relate to the canine metabolism.  Therefore, the objective 
of this study was to investigate the effect of feeding a fish oil containing diet on lipid and 
protein metabolism, postprandial glycemia, and body weight in adult lean dogs. 
 
MATERIALS & METHODS 
Animals and Model 
All animal care procedures were conducted under a research protocol approved by 
the Institutional Animal Care and Use Committee, University of Kentucky, Lexington.  
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Eight  female Beagles (Marshall Bioresources, North Rose, NY), with an average age of 
2.5 years, and initial BW of approximately 8.0 ± 0.7 kg were used in the experiment.  
Dogs were randomly divided into two groups, and each group was randomly assigned to 
one of two diets, control (CO) or fish oil (FO), in a cross-over design.  There were two 
experimental periods and each was 69 days in length.  Experimental periods were 
separated by a wash out period of 30 days to minimize carry-over effects.  The dogs were 
individually housed in kennels (1 x 1.5 m) with a slotted floor in a temperature-controlled 
room with a light:dark cycle of 12 hours at the Division of Laboratory Animal Research 
Facility at the University of Kentucky.  Each kennel was connected to a concrete outside 
run (1 x 2 m) where animals had free diurnal access.  Dogs were also allowed to exercise 
and to have social interaction in outside and/ or inside play area for an average of 3 hours 
daily, except during urine and fecal collection periods.  During nitrogen balance 
collections, dogs were confined to the indoor portion of their kennels for a period of 6 
days, and human interaction was provided for a minimum of 20 minutes per dog daily. 
 
Treatments and Feeding 
Two dry, extruded kibbled diets were used.  All diets were formulated to be 
isonitrogenous and isocaloric.  Diets had similar ingredient compositions and nutrient 
profiles (Tables 4.1 and 4.2, respectively), except that for source of oil.  This replacement 
led to alterations in the fatty acid profile of these diets (Table 4.2).  Diets were formulated 
in accordance with the Association of American Feed Control Officials (2002) nutrient 
guide for dogs and balanced to meet maintenance requirements. 
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Prior to the start of the experiment the dogs were fed Canine Adult Maintenance 
Diet (Hills Science Diet, Topeka, KS), to maintain a constant lean body weight.  At the 
beginning of each experimental period dogs were gradually transitioned onto 
experimental diets over a five day period.  During the experiment the dogs were fed to 
maintain their BW, which was established at the beginning of each experimental period.  
All dogs were with a body condition score (BCS) between 4 and 5 (using a scale from 1 
to 9), which is considered ideal and relates to an animal with ribs easily palpable without 
excess fat covering, waist observed behind ribs and abdomen tucked up. Dogs were fed 
once a day at 0700 in stainless steel bowls.  All dogs were allowed 20 min to consume 
the food.  Any remaining orts were collected, weighed, and recorded.  Water was 
available ad libitum throughout the experiment. 
 
Experimental Procedures 
Blood Sampling 
Venous blood samples (8 mL) were collected on d 0, 30, 60 and 69 via jugular 
puncture into a sodium heparin containing vacutainer (Becton Dickson, Franklin Lakes, 
NJ), and placed on ice for plasma glucose, triglycerides, total cholesterol, -
hydroxybutyrate (BHB), non-esterified fatty acids (NEFA), insulin, glucagon, ghrelin, 
and lipoprotein lipase (LPL) determination.  Blood samples were kept on ice centrifuged 
at 4,000 g for 15 min at 4C.  Plasma samples were stored at -20C until analyses. 
Postprandial Glycemia 
Postprandial glycemia tests were performed at the beginning of the experiment to 
establish baseline values (prior to treatment), and at 30 and 60 days of feeding the 
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experimental diets.  In the morning of the test, an i.v. catheter (22G x 1) was placed in the 
cephalic vein of the dogs and secured with tape and an injection cap and filled with 
heparinized saline (20 units/mL) to ensure patency.  After blood baseline collection and 
subsequent placement of catheters, the dogs were fed their daily ration and allowed 15 
min to consume it.  Postprandial blood samples (3mL) were collected via intravenous 
catheter at 15, 30, 45, 60, 90, 120, 150 and 180 min counted from the starting time of 
food ingestion.  Between sampling times, a heparin solution (20 units of heparin per mL) 
was infused to avoid blood clotting in the catheters.  Once blood sampling was 
completed, catheters were removed.  Blood and plasma samples were processed and 
stored in a similar manner as described for baseline samples. 
 
Nitrogen Balance and Protein Turnover 
Sampling periods began at 0700 on day 63 of each experimental period, when 
dogs entered confinement, and ended at 0700 on day 69.  Dogs were weighed prior and at 
the end of collection periods. 
Total urine was collected at 0700, 1300 and, 1900 daily during the collection 
period.  Urine was collected via catch pans that were approximately 1 x 1.5 m.  These 
pans were made of stainless steel and had one inch raised edges on three sides, with a flat 
edge on one of the 1m sides.  The pans were placed under the slotted floor of the kennels 
and suspended by wire at the back of the kennels so that they were sloping towards the 
front of the kennel.  Fiberglass screens with stainless steel frames were placed on the top 
of each pan to keep hair and feces out of the urine.  A watertight, plastic trough was 
placed under the front edge of the pan to collect the excreted urine.  Eight milliliters of 6 
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N H3PO4 was added into the plastic troughs at the time of placement in order to acidify 
and preserve the urine.  The urine catch pan was rinsed down with water three times daily 
(0700, 1300, and 1900) during the sampling period to ensure complete collection.  Each 
rinse was approximately 80 mL spread evenly over the entire pan.  Total urine collected 
for each individual dog was placed into a tared plastic container.  Fifty percent of the 
total urine collected from a 24 hour period was composited for each dog within 
experimental period and frozen. 
Just before the 0700 feeding on day 66 of each period a single dose (7.5 mg/kg) of 
15N-glycine (Andover, MA, Cambridge Isotope Laboratories, Inc.) was administered 
orally to each dog via a gelatin capsule (size 000, Park City, UT, Nutraceutical Corp.).  
From day 66 at 0700 through day 69 at 0700 25% of acidified urine from each dog was 
separated, composited and frozen for later analysis for 15N-glycine enrichment.  Total 
feces were collected at the same intervals, by removing fecal matter from the slotted floor 
of the kennels as well as from the fiberglass screen on top of the urine catch pan.  After 
collection, feces were weighed, identified, and placed in plastic bags and frozen until 
analysis.  At the end of each collection period fecal samples were composited by animal. 
 
Blood Metabolite Analyses 
Plasma glucose, triglycerides, and total cholesterol concentrations were analyzed 
by Konelab 20 XTi, using available commercial kits (Infinity, Thermo Electron 
Corporation, Louisville, CO). Plasma NEFA was assayed using an enzymatic method 
(Wako NEFA C kit, Wako Diagnostics, Richmond, VA, USA).  Plasma BHB was 
analyzed by enzymatic method (LiquiColor Reagent Kit, Stanbio Laboratory, Boerne, 
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TX, USA).  Aliquots of plasma were analyzed for insulin, glucagon, ghrelin, and 
lipoprotein lipase (LPL) concentrations as previously described by Yamka et al. (2006). 
 
Feed, Fecal and Urine Sample Analyses 
Samples from the two test diets were collected throughout the experimental 
periods and stored at -20˚C until chemical analyses were conducted.  Diet samples were 
ground in a Wiley mill (model 4, Thomas Swedesboro, NJ) through a 2-mm screen.  Each 
diet was analyzed for dry matter (AOAC, 2000), crude protein; calculated from total N 
values (Vario Max CN, Elementar, Hanau, Germany), total dietary fiber (Prosky et al., 
1992), gross energy using an oxygen bomb calorimeter (model 1756, Parr Instruments, 
Moline, IL) and fat content; measured by acid hydrolysis (AACC, 1983) followed by 
ether extraction (Budde, 1952).  Fatty acid profile of experimental diets was analyzed as 
described previously by Fritsch et al. (2010). 
Fecal samples were composited for each dog, within a period, and homogenized.  
Similarly to the diets, feces samples were analyzed for DM, CP and fat content. 
Approximately, 1 g samples of wet feces were dried in a 105°C circulating air oven 
overnight, and difference in weight was used to determine absolute dry matter.  
Approximately 500 mg of wet feces were weighed into crucibles and analyzed as is for 
nitrogen content.  Dried (55°C) ground fecal samples were used to determine fecal fat 
content as described above.  Urine composites were thawed, homogenized and 1 g 
aliquots were weighed into crucibles containing 100 mg of steel wool and 200 mg of 
sucrose to determine nitrogen content.  Urea and 15N nitrogen enrichment contents in 
urine composites prior and post 15N-glycine dosing were analyzed as previously 
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described by Reeder et al. (2011).  All samples were analyzed in duplicate with a 5% 
error allowed between duplicates; otherwise, analyses were repeated. 
 
Calculations 
Postprandial Glycemia 
Incremental area under the curve (IAUC) for plasma glucose values was 
calculated according to method of Wolever et al. (1991) using GraphPad Prism 5 
Software (GraphPad Software, Inc., San Diego, CA).  Peak area for plasma glucose was 
also calculated using GraphPad Prism 5 Software (GraphPad Software, Inc., San Diego, 
CA).  This software calculates the area under the curve using the trapezoid rule.  It 
permits to separation of the data into different regions as a fractional of the total area and 
to calculate the highest point of each region (peak). 
 
Nitrogen Balance 
All nitrogen balance calculations were done on a dry matter (DM) basis.  Nitrogen 
from feed was considered nitrogen intake, while nitrogen from urine composites and 
feces were nitrogen outputs. Apparent nitrogen absorption (NA), nitrogen retention (NR), 
%DM digestibility, and apparent  %nitrogen (N) digestibility were calculated, with all 
values on a g/d basis, as: 
NA (g/d) = (N from intake – N from feces) 
 
NR (g/d) = N absorbed – N from urine 
 
% DM digestibility = (DM intake – DM output) *100 
                                                (DM intake) 
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% N digestibility = (N intake – N from feces) *100 
                                                            (N intake) 
 
% N balance = (N intake – (N from feces + N urine) *100 
                                                    (N intake) 
 
 
Whole body protein turnover was measured using the 15N-glycine single-dose 
urea end-product method (Waterlow et al., 1978).  This procedure assumes that 15N-
glycine will be partitioned mainly between protein synthesis and oxidation in the same 
proportion as total amino acid turnover, and that oxidized end products are excreted 
quantitatively in the urine.  Therefore, by measuring the amount of 15N-glycine not 
incorporated into body tissues, protein turnover (g N/d) can be calculated (Wessels et al., 
1997).  Whole body protein turnover was calculated as: 
Q = d/G 
where Q represents protein turnover (g N/d), and d is the rate of urea N excretion (g/d) 
from day 66 1300 through day 69 at 0700.  The samples from day 66 0700 were not 
included since they represented urine that was excreted before the 15N-glycine dose was 
administered.  In the equation, G represents the fractional recovery of 15N from 15N-
glycine in urine urea.  The 15N enrichment of all urine samples was corrected for 
background 15N enrichment (Wessels et al., 1997).  From whole body protein turnover, 
protein synthesis (PS) and protein degradation (PD) were calculated using the following 
equations: 
PS (g N/d) = [Q – (N excreted in urine)] 
PD (g N/d) = [Q – (N intake – N in feces)] 
where N excreted in urine, N intake, and N in feces were all represented on a (g N/day) 
basis. 
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Statistical Analysis 
Data from post-prandial glycemia test and plasma hormones and lipid metabolites 
were analyzed as repeated measurements in a cross-over design using the Mixed 
procedure of SAS (SAS Inst., Inc., Cary, NC).  All other variables were analyzed by the 
Mixed procedure of SAS (SAS Inst., Inc., Cary, NC).  The statistical model included the 
fixed effect of treatment, and the random effects of period and animal.  All treatment 
least squares means were compared to each other and Tukey adjustment was used to 
control for experiment wise error.  Differences between means with P < 0.05 were 
considered significant and means with P<0.10 were considered trends. 
 
RESULTS 
Postprandial Glycemia 
Incremental AUC and peak area for glucose (Table 4.3) were not affected 
(p>0.05) by dietary treatment or among sampling days within treatment.  Likewise, no 
difference (p>0.05) in body weight was observed between the CO and FO treatments 
throughout the experiment. 
 
Blood Metabolites 
A treatment x day interaction was observed for cholesterol (p=0.0271). While it 
did not differ in the FO treatment, fasting plasma CHOL was increased throughout the 
experiment when compared to baseline value for the CO diet (Table 4.4).  Plasma CHOL 
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concentration also tended to be lower in the FO when compared to CO diet on d 30.  On d 
60, CHOL concentration was decreased in the FO versus the CO treatment.  There was 
no treatment x day interaction (p=0.1103) for fasting plasma triglyceride concentration; 
however, there was an effect of treatment (p=0.0289). The FO treatment had a higher 
TRIG than the CO treatment.  A significant treatment x day interaction existed for fasting 
plasma NEFA concentration (p=0.0053).  In the FO treatment, NEFA was decreased on d 
30 in comparison to d 69 (p=0.0010) and d 69 tended to be increased when compared to 
baseline (p=0.09), whereas no difference was observed in the CO treatment.  Likewise, a 
treatment x day interaction was observed for fasting BHB (p=0.0392).  In the CO 
treatment, BHB was only increased on d69 when compared to baseline, whereas on the 
FO diet, BHB decreased at d 30 when compared to d0 and increased at d 69 when 
compared to d 0, 30 and 60. 
For fasting plasma LPL concentration (Table 4.4) a day effect was observed 
(p=0.0083) and a tendency (p=0.1051) for the FO treatment to have a higher LPL value 
versus the CO treatment.  For fasting plasma ghrelin concentration there was a main 
effect of treatment and day.  The FO treatment had increased levels of ghrelin (p=0.0051) 
and all days differed from each other except between d 30 and 60 when no effect of day 
was depicted.  There was no treatment x day interaction or main treatment effect for 
fasting plasma glucagon, insulin, or glucose. 
 
Nutrient Digestibility, Nitrogen Balance and Protein Turnover 
Food intake was similar between the CO and FO treatments (Table 4.5) and fecal 
excretion was increased (p=0.0361) in the FO treatment.  This resulted in decreased dry 
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matter digestibility (p=0.0247) and fat digestibility tended to be lower (p=0.1084) for the 
FO diet.  Nitrogen intake, fecal and urine N excretion, N absorbed, N digestibility, N 
retained, and N balance did not differ between the treatments (Table 4.6). In addition, 
there was no change in body weight during the nitrogen balance periods in both 
treatments.  Protein turnover, synthesis and degradation were similar in dogs fed the CO 
and the FO diets. 
 
DISCUSSION 
 Omega 3 fatty acids, mainly DHA and EPA, from fatty cold water fish have been 
alluded to have anti-obesity properties (Ruzickova et al., 2004; Baillie et al., 1999; 
Hainault et al. 1993), to enhance protein metabolism (Hayashi et al., 1999; Selleck et al., 
1994; Mendez et al., 1992; Teo et al., 1989), to decrease plasma cholesterol and 
triglycerides (Kim and Choi., 2005; Mori et al., 1999), and to improve glycemic response 
(Ajiro et al., 2000; Feskens et al., 1991).  Most of the research conducted in this area, 
however, has been performed using murine and human models and these findings may 
not always mirror the canine metabolism.  Additionally, not much attention has been paid 
to the supplementation of fish oil to healthy models.  Fish oil may have a preventive 
effect on the onset of metabolic syndrome, as well as on metabolic processes relate to 
aging; decreased insulin sensitivity and increased protein catabolism.  Thus, the objective 
of this study was to determine the effect of feeding a fish oil containing diet on lipid and 
protein metabolism, postprandial glycemia, and body weight in adult lean dogs. 
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Postprandial Glycemia 
In this study, the postprandial glycemic test was used to determine the effect of 
FO treatment on the dogs’ ability to clear blood glucose after ingestion of a mixed meal.  
The animals in this experiment were young adult lean female dogs, therefore it was 
expected that these dogs would not have disorders related to the metabolism of 
carbohydrates, such as insulin resistance, which has been suggested in animals with 
increased fat mass (Larson et al., 2003).  It was hypothesized in this study, that 
supplementation of FO would further improve insulin sensitivity in these dogs, which 
could result in smaller glucose IAUC and peak area.  Dietary intake of FO has been 
shown to have an antiobesity effect, thus it was also anticipated that there would be a 
protective effect of FO supplementation against body weight gain in these animals.  Pet 
foods are energy-dense and formulated to exceed the dogs’ minimum nutrient 
requirements, which may predispose dogs to become obese. 
In contrast to our hypothesis, the results of the current experiment showed no 
effect of FO treatment on glucose IAUC or peak area, as well as body weight.  In this 
study, glucose IAUC fell within ranges reported for healthy dogs (Lubbs et al., 2010).  In 
support of our data, dietary supplementation with ω3 PUFA did not improve insulin 
sensitivity or glucose disposal in healthy non-obese dogs (Irvine et al., 2002).  In the 
latter study, the authors suggested that the lack of response to the FO supplementation 
was due to the fact that the dogs were insulin sensitive.  Similar factors could have played 
a role in the current study.  Additionally, it is possible that a longer treatment period, 
higher dosage of FO, and increased number of animals would be necessary in order to 
improve the effectiveness of the FO treatment.  Fritsch et al. (2010) reported that a 
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supplementation of 2.94% of EPA and DHA during 90 days was effective in improving 
weight bearing and lameness in 60 osteoarthritic dogs.  In murine models a preventive 
effect of FO supplementation on the development of insulin resistance has been indicated 
(Clarke, 2000; Podolin et al., 1998).  Therefore, further research in this area may be 
warranted before the preventive role of the supplementation of FO in disorders related to 
carbohydrate metabolism in the canine model is precluded. 
 
Blood Metabolites 
Physiological serum CHOL concentration for healthy dogs ranges from 3.6-5.4 
mmol/L (Jones and Manella, 1990).  In this study, plasma CHOL concentrations were 
within the normal physiological range and in agreement with literature values reported 
for adult young lean dogs, 4.47 to 5.39 mmol/L (Pasquini et al., 2008; Jeusette et al., 
2005a).  Fasting plasma CHOL concentration in the FO treatment did not differ 
throughout the experiment when compared to its baseline value.  In contrast, CHOL 
levels were consistently increased during the experimental period in the CO group.  This 
suggests that supplementation of FO had a protective effect against a plasma CHOL rise 
in adult lean dogs, specially at d 60 of supplementation when dogs on the FO diet had a 
10% decrease in plasma cholesterol compared to the dogs on the CO diet.  In support of 
our data, Wright-Rodgers et al. (2005) reported that gestating and lactating dogs fed a 
diet rich in marine ω3 PUFA had lower CHOL concentrations (4.9 mmol/L) in contrast to 
dogs fed diets with low levels of FO or high levels of -linolenic acid from linseed oil.  
In this experiment, fasting plasma TRIG concentration was within the limits reported for 
healthy adult dogs, 0.6  0.3 mmol/L (Jones and Manella, 1990) and supplementation 
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with FO led to an increase in plasma TRIG.  These findings differ from those seen in 
human, rodent and canine studies in which dietary FO either decreased or had no effect 
on plasma TRIG levels (Ulven et al. 2011; Fakhrzadeh et al., 2010; Harris, 1999; Moris 
et al., 1999; Sanchez-Muniz et al., 1999; McAlister et al., 1996).  The increased plasma 
TRIG (3%) observed in the FO treatment seems to be an effect of higher baseline values 
observed on d0 rather than a treatment effect. In addition, the dogs on this diet were not 
hyperlipidemic, which is characterized by plasma TRIG concentrations above 1.7 
mmol/L (Jones and Manella, 1990).  Mean plasma NEFA and BHB concentrations were 
similar to the values reported for adult dogs 0.97  0.09 mmol/L and 0.02-0.15 mmol/L, 
respectively (Bailhache et al. 2003; Duarte et al., 2002).  Changes in plasma NEFA 
followed similar patterns observed for plasma BHB concentrations. 
Lipoprotein lipase is an important enzyme in the regulation of glucose disposal by 
the adipose and muscle tissues.  Because of the non-invasive nature of this study, tissue 
biopsies (muscle and adipose) could not be performed.  Instead, fasting plasma LPL 
concentration was analyzed as indirect method to verify dietary treatment effects on lipid 
metabolism.  A recent study has demonstrated a numeric increase in plasma LPL activity 
after ω3 PUFA supplementation (Rudkowska et al., 2010).  In the present study, no 
differences in plasma LPL concentration were detected by supplementation of FO, 
although the FO treatment showed a tendency toward higher plasma LPL concentration.  
It’s important to acknowledge, however, that plasma LPL concentration may not reveal 
local regulation and activity of this enzyme in muscle and adipose tissues.  In agreement 
studies demonstrated that FO supplementation did not influence plasma LPL activity in 
humans (Nozaki et al., 1991; Harris et al., 1988), whereas others found FO 
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supplementation to be effective in increasing plasma LPL activity (Harris et al., 1997; 
Kasim-Karakas et al., 1995). 
A consistent indirect relationship between fasting plasma ghrelin and fat mass has 
been reported in several experimental models (Jeusette et al., 2005a,b; Ariyasu et al., 
2002; Shiiya et a., 2002; Tschop et al., 2001).  In this study, plasma ghrelin 
concentrations for the CO and FO treatments are slightly above values reported for lean 
adult dogs; 4.1  0.46 ng/ml (Jeusette et al., 2005a,b).  However, our data are agreement 
with the literature that shows that lean animals have higher ghrelin levels when compared 
to obese animals and that FO treated subjects have increased ghrelin concentration versus 
the control (Ramel et al., 2009).  In this study, an increase in plasma ghrelin of 
approximately 12% was observed in dogs supplemented with FO.  A previous study 
conducted in our laboratory (presented in chapter 3) also supports that FO augments 
plasma ghrelin concentration and that obese dogs have lower levels of this hormone. 
No change in fasting glucagon concentration or treatment effect was observed. A 
range for fasting plasma glucagon of 48-57 pg/ml has been reported for adult dogs (Ionut 
et al., 2008; Sakurai et al., 1974) whereas ours ranged from 60-100 pg.mL. Serum insulin 
concentrations for dogs range between; 6-24 pg/ml (Kaneko, 2008) and fasting insulin 
values in the current study were at least ten times greater.  While it is not known the 
reason for the higher plasma levels of these hormones, differences in experimental design 
and laboratory analyses should not be eliminated.  Fasting glucose levels were within 
normal physiological range for healthy adult dogs (Kaneko, 2008) and unaffected by 
treatment. 
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Nutrient Digestibility, Nitrogen Balance and Protein Turnover 
Food intake was not affected by dietary treatments.  This result was expected 
because fish products are known to be palatable to dogs (Folador et al., 2006).  Despite 
the similarities in the ingredient composition between the diets, fecal excretion was 
increased in the FO treatment resulting in decreased dry matter and fat digestibilities.  
Although, DM and fat digestibility values were lower than the CO diet, they are in 
agreement with the literature which has shown DM digestibility of dog food with 
equivalent ingredient composition (e.g. majority of nutrients coming from poultry meal 
and brewers rice) to be around 80-90% (Faber et al., 2010; Barry et al., 2009; Zinn et al., 
2009; Middelbos et al., 2007) and fat digestibility to be greater than 90% (Faber et al., 
2010; Zinn et al., 2009; Middelbos et al., 2007).  The reason for the lower DM and fat 
digestibilities for the FO treatment for the current study is not known.  These results also 
differ from the data obtained from the previous study using the mature overweight canine 
model, where there was no effect of dietary treatment on fecal excretion, DM and fat 
digestibilities.  It has been suggested that older dogs have increased fat, protein and 
energy digestibilities (Harper, 1998; Sheffy et al., 1985; Lloyd and McCay, 1954), which 
could be a possible explanation for the findings observed in the current study.  Our data 
also suggests that younger dogs would be less capable of digesting lipid sources rich in 
PUFA, since only the fat digestibility for the FO diet was decreased when compared to 
the fat digestibility observed in our previous study using the mature canine model, where 
fat digestibility for both diets (CO and FO) where around 96-97%.  However, it’s 
important to acknowledge that conflicting information exist on the increased nutrient 
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digestibility of older dogs, as some research indicated no significant age-related change 
(Taylor et al., 1995; Buffington et al., 1989). 
Food nitrogen intake, N digestibility, N retention, and N balance were similar 
between the dietary treatments.  Likewise, protein turnover, synthesis and degradation 
were not affected by the FO diet.  Omega 3 PUFA from fish oil has been shown to 
improve protein metabolism and to have a protein sparing effect in catabolic illness 
(Hayashi et al., 1999; Selleck et al., 1994; Mendez et al., 1992; Teo et al., 1989; 
DeMichele et al., 1988; Trocki et al 1987; Alexander et al., 1986).  No data could be 
found about protein kinetics and fish oil supplementation in lean and/ or healthy animal 
models.  However, it is possible that young adult dogs have reduced catabolic and 
inflammatory processes, making them a more challenging model to detect health benefits 
associated with fish oil supplementation, mainly in a short-term experiment. 
Body weight did not differ between treatments.  Although fish oil has been shown 
to be beneficial in weight loss, the data still not conclusive and some studies have found 
no significant effect using mouse and rat models (Gaiva et al., 2001; Takahashi and Ide, 
2000; Hun et al., 1999).  In addition, the alleged effects of fish oil in weight loss 
treatments seem to be most effective in obese models (Kunesova et al., 2006; Thorsdottir 
et al., 2007), which differs from the young lean adult dog model used in this study.  In 
support to our data, Brilla and Landerholm (1990) found no beneficial effect of fish oil 
supplementation and/ or exercise treatment in healthy adult men.  The authors suggested 
the lack of effect of fish oil and exercise to be related to the limiting capacity of the 
subjects in further reduce their fat mass.  In the current study, similar constrains could 
have blunted the effect of fish oil treatment, since the dogs were lean and very active.  It 
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was expected that the FO diet, would improve protein metabolism and help maintaining 
the lean body mass of the animals, which was measured indirectly by N balance and 
protein turnover.  Even though fish oil did not boost the protein metabolism and probably 
did not affect lean mass in this model (not measured in the experiment), it is important to 
emphasize that these animals were fed to maintain their ideal body weight.  Animals fed 
ad libitum may benefit from fish oil supplementation.  Research has shown 
supplementation of DHA and EPA to be favorable in weight loss of mice fed free-choice 
(Flachs et al., 2006).  Additionally, no research has been done looking at the long term 
effects of feeding a fish oil containing diet to dogs.  Early supplementation of fish oil 
may delay the onset of aging processes; protein catabolism and development of insulin 
insensitivity.  Wray-Cahen et al. (1997) and Davis et al. (1998) stated that there is a 
decline in the sensitivity of muscle protein metabolism to insulin from neonatal period to 
maturity.  Gringas et al. (2007) suggested that maintenance of muscle mass during 
adulthood could also be an important strategy in addressing the obesity epidemic because 
muscle mass partially defines basal metabolic rate. 
In summary, feeding a FO containing diet showed a protective effect against the 
rise of CHOL and to be effective in increasing plasma ghrelin.  However, it did not 
appear to improve protein metabolism and postprandial glycemia in adult lean dogs.  
Discoveries on the long term supplementation of FO in the canine model might assist the 
pet food industry as well as pet owners to improve the life quality and health of dogs. 
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Table 4. 1.  Ingredient composition of control (CO) and fish oil (FO) diets fed to adult 
lean dogs. 
  Treatment 
CO FO 
Ingredients, % as fed basis   
Rice, Brewers   43.70 43.70 
Corn-Starch      22.60 22.60 
Poultry Meal 13.80 13.80 
Poultry Fat   7.60 7.60 
Corn Gluten Meal     4.50 4.50 
Soybean oil    2.00 -- 
Fish Oil -- 2.00 
Cellulose    2.00 2.00 
Potassium Chloride     1.00 1.00 
Palatability Enhancer 1.00 1.00 
Dicalcium Phosphate 0.71 0.71 
L-Lysine  0.40 0.40 
Salt, Iodized    0.25 0.25 
Choline Chloride     0.17 0.17 
Calcium Carbonate   0.10 0.10 
Vitamin mix 0.10 0.10 
Mineral Mixa   0.05 0.05 
Magnesium Oxide    0.03 0.03 
a Formulated to supply at least (g/kg of food): 0.6 Mg, 1.8 Na, 7.0 K, 7.6 Cl, (mg/kg of 
food) 211 Fe, 163 Zn, 13 Cu, 13 Mn, 0.4 Se, 1.5 I (IU/g of food) 18.2 Vitamin A, 1.0 
Vitamin D, 0.18 Vitamin E (mg/kg of food) 0.3 Biotin, 1484 Choline, 1.9 Folic acid, 62 
Niacin, 18 Pantothenic acid, 8.6 Pyridoxine, 8.0 Riboflavin, 41 Thiamin, and 0.13 
Vitamin B12 
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Table 4. 2.  Chemical composition of control (CO) and fish oil (FO) diets fed to adult 
lean dogs. 
 
  Treatment 
CO FO 
Item     
DM, % 92.40 92.80 
%, DM basis 
Acid hydrolyzed fat 14.70 14.33 
Total dietary fiber 5.1 5.3 
Crude protein  19.3 18.7 
Ash 4.06 3.95 
Gross energy, kcal/kg 4,608 4,584 
C18:0 Octadecanoic (Stearic) 1.40 1.32 
C18:1 Octadecenoic (Oleic) 5.23 4.81 
C18:2 Octadecadienoic Omega 6 3.29 2.00 
C18:3 Octadecatrienoic Omega 3 0.19 0.10 
C18:4 Octadecatetraenoic Omega 3 < 0.01 0.06 
C20:0 Eicosanoic (Arachidic) 0.03 0.03 
C20:2 Eicosadienoic Omega 6 0.06 0.06 
C20:3 Eicosatrienoic Omega 3 0.01 0.01 
C20:4 Eicosatetraenoic Omega 6 0.06 0.09 
C20:5 Eicosapentaenoic Omega 3 0.02 0.39 
C21:5 Heneicosapentaenoic Omega 3 < 0.01 0.01 
C22:2 Docosadienoic Omega 6 < 0.01 < 0.01 
C22:3 Docosatrienoic Omega 3 < 0.01 < 0.01 
C22:4 Docosatetraenoic Omega 6 0.02 0.02 
C22:5 Docosapentaenoic Omega 3 0.01 0.04 
C22:6 Docosahexaenoic Omega 3 0.01 0.25 
Total Omega 3 0.24 0.86 
Total Omega 6 3.47 2.21 
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Table 4. 3.  Postprandial glycemic response in adult lean dogs consuming soy oil (CO) or fish oil (FO) containing diet. 
Treatment 
CO FO 
d0 d30 d60 d0 d30 d60 SEM 
Item 
Incremental area under the curve 
(0-180 min), (min•mmol)/L 125.0 104.2 105.0 115.2 87.2 118.7 16.46 
Peak area 123.5 106.7 106.1 111.0 64.0 126.9 17.97 
Body weight, kg 8.2 8.3 8.4 8.2 8.3 8.3 0.37 
 SEM=pooled SEM, n=8. 
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Table 4. 4. Fasting plasma lipid metabolites, lipoprotein lipase (LPL), ghrelin, glucagon, insulin, and glucose in adult lean 
dogs consuming soy oil (CO) or fish oil (FO) containing diet. 
Treatment 
CO FO 
d0 d30 d60 d69 d0 d30 d60 d69 SEM 
Item, mmol/L   
Cholesterol* 4.76a 5.40d 5.37d 5.35cd 4.82ab 4.91abcd§ 4.88abc 5.31bcd 0.350 
Triglycerides** 0.33 0.39 0.37 0.49 0.42 0.40 0.37 0.51 0.020 
Non esterified fatty acids 0.97ab 1.24bc 1.16bc 1.17bc 1.00abc 0.86a 1.04abc 1.28c† 0.082 
-hydroxybutyrate 0.06ab 0.05ab 0.06ab 0.09cd 0.07bc 0.04a 0.05ab 0.12d 0.013 
          
LPL, ng/ml† 64.0 69.2 70.3 72.3 61.4 78.0 80.7 74.5 6.76 
Ghrelin, ng/ml** 5.2 6.0 6.0 7.8 5.7 7.3 6.9 8.1 0.66 
Glucagon, pg/ml 60.8 80.3 70.1 97.0 63.9 85.7 67.5 67.6 18.24 
Insulin, pg/ml 251.2 232.0 270.0 325.2 266.5 311.2 230.5 347.5 75.12 
Glucose,  mmol/l 5.1 5.0 5.3 5.3 5.0 5.4 5.2 5.6 0.24 
 a-d Means in the same row not sharing common superscript letters are different (P<0.05). SEM=pooled SEM, n=8. 
* Day x treatment interaction (p<0.05).  
** Treatment effect (p<0.05). 
§ Trend to differ from d30 of CO treatment (p<0.10). 
† Trend to treatment effect (p<0.10).  
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Table 4. 5.  Food intake (DM), fecal excretion, dry matter and fat digestibility in dogs 
consuming soy (CO) or fish oil (FO) containing diet. 
 Treatments     
Item CO FO SEM P- value1 
Food Intake (g DM/d) 151.3 151.1 4.81 0.9819 
Fecal Excretion (g DM/d) 14.3 16.7 0.76 0.0361 
DM Digestibility (%) 90.6 88.9 0.47 0.0247 
Fat Digestibility (%) 96.4 94.9 0.61 0.1084 
1 Main treatment effect. SEM = pooled SEM, n=8. 
 
 
 
 
Table 4. 6.  Nitrogen metabolism in dogs administered 15N – glycine and body weight 
change of dogs fed control (CO) and fish oil (FO) diets. 
Treatments     
Item CO FO SEM P-value 
Food N Intake, g/d 4.62 4.57 0.147 0.8177 
Fecal N Excretion , g/d 0.28 0.32 0.019 0.1229 
Urine N Excretion, g/d 3.43 3.37 0.143 0.7616 
 
N Absorbed, g/d 4.34 4.24 0.146 0.6395 
N Digestibility, % 93.95 92.82 0.470 0.1124 
N Retained, g/d 0.91 0.87 0.140 0.8577 
N balance, % 19.50 18.78 2.759 0.8553 
     
Protein turnover (g N/d) 8.53 8.44 0.524 0.8449 
Protein synthesis (g N/d) 5.93 5.83 0.488 0.8325 
Protein degradation (g N/d) 4.19 4.20 0.516 0.9888 
 
Body weight change ,kg 0.10 0.14 0.040 0.5430 
1 Main treatment effect. SEM = pooled SEM, n=8. 
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CHAPTER 5: INCREMENTAL LEVELS OF BARLEY IN CANINE DIETS: 
INFLUENCE ON APPARENT NUTRIENT DIGESTIBILITY, FECAL QUALITY 
AND ODOR, AND POSTPRANDIAL GLYCEMIA AND INSULINEMIA IN 
ADULT DOGS 
 
INTRODUCTION 
In recent years, the human population has become progressively aware of the 
importance of nutrition for the maintenance of optimal health.  Despite it, the incidence 
of obesity and other chronic diseases is still increasing worldwide.  Similarly to humans, 
companion animals also have a high incidence of chronic diseases.  Dogs and cats have 
shared the same environment, food and life style of their owners; therefore it is not 
surprising these animals suffer from similar health problems.  In the area of human 
nutrition, several approaches have been investigated to address this serious public health 
issue.  The interest in functional ingredients has increased because they have shown to be 
beneficial in the control or prevention of obesity, diabetes mellitus, cancer, 
hypercholesteremia, as well as other chronic diseases.  Among these functional 
ingredients, barley (Hordeum vulgare L.) has become a popular carbohydrate choice due 
to its high concentration of complex carbohydrates and -glucans, two important 
constituents of dietary fiber (Asare et al., 2011). 
Some of the health benefits observed with the ingestion of dietary fibers are 
related to their lower energy density as compared to other carbohydrate fractions such as, 
starch, but also to their potential to increase satiety and to slow down digestive and 
absorptive processes due to slower rate of gastric emptying and due to increased viscosity 
of the digesta in the gastrointestinal tract.  Additional benefits associated with the 
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ingestion of barley or its fiber components are: the cholesterol-lowering property 
(Queenan et al., 2007; Anderson et al., 1990) and the decreased insulinemic and glycemic 
response observed in healthy and diabetic patients (Mello and Laaksonen, 2009). 
Because humans have developed strong emotional bonds with their companion 
animals, pet owners have been particularly concerned with the health of their pets and 
have sought for similar nutritional approaches as to their own, to improve the life quality 
and longevity of their pets.  However, limited information on the health benefits of 
dietary supplementation of barley is available for the canine.  Therefore, the objective of 
this study was to examine the effects of incremental levels of barley on apparent nutrient 
digestibility, fecal short chain fatty acid concentrations, fecal quality and odor, and 
postprandial glycemic and insulinemic responses in adult dogs. 
 
 
MATERIALS & METHODS 
Animals and Model 
All animal care procedures were conducted under a research protocol approved by 
the Institutional Animal Care and Use Committee, University of Kentucky, Lexington.  
Sixteen female dogs; eight purpose-bred mature female dogs with an average age of 10 
years, and initial BW of approximately 22.6 ± 3.2 kg and eight young female Beagles 
with an average age of 3.5 years and initial BW of 8.2 ± 0.8 kg were used in the 
experiment.  Dogs were blocked by age and 4 experimental diets; control (40% corn) or 
three levels of barley (10, 20, and 40%) were randomly assigned within each block giving 
4 dogs per diet, 2 young and 2 senior.  This process was repeated for a second 
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experimental period with one constraint, no dog received the same diet twice, giving a 
total of 8 dogs for each diet.  In order to facilitate sample collection, dogs were divided in 
two groups within experimental period intercalated by a week.  Each group was 
comprised of four dogs of each age block.  Experimental periods were 14 days in length; 
a 9-d adaptation phase followed by a 4-d confinement for collection of urine and feces, 
followed by a 1-d post-prandial glycemia test, and were separated by a wash out period of 
7 days to minimize carry-over effects.  The dogs were individually housed in kennels (1 x 
1.5 m) with a slotted floor in a temperature-controlled room with a light: dark cycle of 12 
hours at the Division of Laboratory Animal Research Facility at the University of 
Kentucky. Each kennel was connected to a concrete outside run (1 x 2 m) where animals 
had diurnal access.  Dogs were also allowed to exercise and to have social interaction in 
outside and/ or inside play area for an average of 3 hours daily, except during urine and 
fecal collection periods.  During nitrogen balance collections, dogs were confined to the 
indoor portion of their kennels for a period of 4 days, and human interaction was 
provided for a minimum of 20 minutes per dog daily. 
 
Treatments and Feeding 
Four dry, extruded kibbled diets were used.  All diets were formulated to be 
isonitrogenous and isocaloric.  Diets had similar ingredient compositions and nutrient 
profiles (Tables 5.1).  The dietary treatments were: control (40% corn, CO) and three 
diets with incremental levels of barley (10, 20 or 40%; BA10, BA20 and BA40) added at 
the expensive of whole yellow corn.  This incremental substitution of barley led to 
alterations in the total dietary fiber content of the diets (Table 5.1).  Diets were 
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formulated in accordance with the Association of American Feed Control Officials 
(2002) nutrient guide for dogs and balanced to meet maintenance requirements. 
All dogs were adapted to the control diet prior to the start of the experiment.  
During the experiment the dogs were fed to maintain their BW, which was established at 
the beginning of each experimental period.  Dogs were fed once a day at 0700 in stainless 
steel bowls.  All dogs were allowed 15 minutes to consume the food in order to condition 
them to meal feeding.  Any remaining orts were collected, weighed, and recorded.  At the 
beginning of each experimental period, dogs were abruptly switched to their assigned 
experimental diets to evaluate potential adaptation concerns with newly introduced 
carbohydrate sources; measured by fecal score (48h).  Water was available ad libitum 
throughout the experiment. 
 
 
Experimental Procedures 
Apparent Nutrient Digestibility and Nitrogen Balance 
Sampling periods began at 0700 on day 10 of each experimental period, when 
dogs entered confinement, and ended at 0700 on day 14.  Dogs were weighed prior and at 
the end of collection periods.  Total urine was collected at 0700, 1300 and, 1900 daily 
during the collection period.  Urine was collected via catch pans that were approximately 
1 x 1.5 m.  These pans were made of stainless steel and were placed under the slotted 
floor of the kennels and suspended by wire at the back of the kennels so that they were 
sloping towards the front of the kennel.  Fiberglass screens with stainless steel frames 
were placed on the top of each pan to keep hair and feces out of the urine.  A watertight, 
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plastic trough was placed under the front edge of the pan to collect the excreted urine.  
Eight milliliters of 6 N H3PO4 was added into the plastic troughs at the time of placement 
in order to acidify and preserve the urine.  The urine catch pan was rinsed down with 
water three times daily (0700, 1300, and 1900) during the sampling period to ensure 
complete collection.  Each rinse was approximately 80 mL spread evenly over the entire 
pan.  Total urine collected for each individual dog was placed into a tared plastic 
container.  Fifty percent of the total urine collected from a 24 hour period was 
composited for each dog within experimental period and frozen. 
Total feces were collected at the same intervals, by removing fecal matter from 
the slotted floor of the kennels as well as from the fiberglass screen on top of the urine 
catch pan.  After collection, feces was weighed, identified, and placed in plastic bags and 
frozen at -20⁰C.  At the end of each experimental period 50% of the daily fecal excretion 
was composited by animal.  All fecal samples were scored for consistency throughout 
each experimental period according to the following system: 1 = hard, dry pellets; small, 
hard mass; 2 = hard-formed, dry stool; remains firm and soft; 3 = soft, formed, and moist 
stool, retains shape; 4 = soft, unformed stool; assumes shape of container; and 5 = 
watery; liquid that can be poured.  On day 4 of fecal collection, an aliquot of fresh feces 
was collected and frozen (-20°C) until analysis of phenol, indole, and biogenic amine 
concentrations.  A second aliquot of fresh feces (2 mg) was collected and weighed into 5 
mL of 5% metaphosphoric acid for short chain fatty acid (SCFA) analysis. 
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Postprandial glycemia 
Postprandial glycemia tests were performed on day 14 of each experimental 
period.  In the morning of the test, venous blood samples (5 mL) were collected via 
jugular puncture into a sodium heparin containing vacutainer (Becton Dickson, Franklin 
Lakes, NJ), and placed on ice for plasma glucose and insulin analyses. Subsequently, an 
i.v. catheter, 22gx1 or 20gx 1 ¼ (Terumo Medical Corporation, Somerset, NJ), was 
placed in the cephalic vein of the Beagles and purpose-bred dogs, respectively, and 
secured with tape and an injection cap and filled with heparinized saline (20 units/mL) to 
ensure patency.  After blood baseline collection and placement of catheters, the dogs 
were fed their daily ration and allowed 15 min to consume it. Postprandial blood samples 
(3mL) were collected via intravenous catheter at 15, 30, 45, 60, 90, 120, 150, 180, 240, 
and 300 min counted from the starting time of food ingestion.  Between sampling times, 
heparin solution was infused to avoid blood clotting in the catheters.  Once blood 
sampling was completed, catheters were removed.  Blood samples collected in sodium 
heparin containing vacutainer were kept on ice and centrifuged at 4000 x g for 20 
minutes at 4C (Sorvall RT6000B, Newton, CT).  Plasma samples were stored at -20C 
until analysis. 
 
Feed, Fecal and Urine Sample Analyses 
Samples from the four test diets were collected throughout the experimental 
periods, composited and stored at -20˚C until chemical analyses were conducted.  Diet 
samples were ground in a Wiley mill (model 4, A.H. Thomas Swedesboro, NJ) through a 
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2-mm screen.  Each diet was analyzed for dry matter, ash (AOAC, 2000), crude protein; 
calculated from total N values (Vario Max CN, Elementar, Hanau, Germany), total 
dietary fiber (Prosky et al., 1992), gross energy using an oxygen bomb calorimeter 
(model 1756, Parr Instruments, Moline, IL) and fat content; measured by acid hydrolysis 
(AACC, 1983) followed by ether extraction (Budde, 1952). 
Similarly to the diets, fecal samples were analyzed for DM, CP and fat content. 
Approximately, 1 g samples of wet feces were dried in a 105°C circulating air oven 
overnight, and difference in weight was used to determine absolute dry matter.  
Approximately 500 mg of wet feces was weighed into crucibles and analyzed as is for 
nitrogen content.  Dried (55°C) ground fecal samples were used to determine fecal fat 
and TDF contents as described above. Fecal SCFA concentrations were determined using 
gas chromatography according to methods described previously (Strickling et al., 2000).  
Phenol and indole were extracted from fecal samples according to methods described by 
Flickinger et al. (2003) and determined via HPLC according to methods described by 
Niwa (1993).  Biogenic amines were quantified via HPLC according to methods 
described by Flickinger et al. (2003). 
Urine composites were thawed, homogenized and 1 g aliquots were weighed into 
crucibles containing 100 mg of steel wool and 200 mg of sucrose to determine nitrogen 
content as described above. 
 
Blood Metabolite Analyses 
Plasma glucose and cholesterol concentrations were analyzed by Konelab 20 XTi, 
using available commercial kits (Infinity, Thermo Electron Corporation, Louisville, 
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CO).  Plasma insulin concentrations were determined by radioimmunoassay using 
available commercial kit (Canine Coat-A-Count –Siemens Healthcare Diagnostics, Los 
Angeles, CA). 
 
Calculations 
Apparent Nutrient Digestibility and Nitrogen Balance 
All apparent nutrient digestibility and nitrogen balance calculations were done on 
a dry matter (DM) basis.  Nutrient digestibility was calculated based on total fecal matter 
excreted during the collection phase of each period.  For the nitrogen balance, nitrogen 
from feed was considered nitrogen intake, while nitrogen from urine composites and 
feces were nitrogen outputs.  Apparent nitrogen absorption (NA), nitrogen retention 
(NR), %DM digestibility, and apparent % nitrogen (N) or nutrient  digestibility were 
calculated, with all values on a g/d basis, as: 
% DM digestibility = (DM intake – DM output) *100 
                                                (DM intake) 
 
 
% N digestibility = (N intake – N from feces) *100 
                                                    (N intake) 
 
NA (g/d) = (N from intake – N from feces) 
NR (g/d) = N absorbed – N from urine 
N balance = (N intake – (N from feces + N urine) *100 
                                                    (N intake) 
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Postprandial glycemia and insulinemia 
Glucose incremental and decremental area under the curve (IAUC and DAUC, 
respectively) and insulin AUC were calculated according to method of Wolever et al. 
(1991) using GraphPad Prism 5 Software (GraphPad Software, Inc., San Diego, CA).  
This software calculates the area under the curve using the trapezoid rule.  It allows to 
separate the data in different regions as a fractional of the total area and to calculate the 
highest point of each region (peak). 
 
Statistical Analysis 
Data were analyzed as a generalized randomized complete block design, with 
period as a repeated measurement using the Mixed procedure of SAS (SAS Inst., Inc., 
Cary, NC).  Data for discontinuous variables were analyzed by the GLIMMIX procedure 
(SAS Inst., Inc., Cary, NC).  The statistical model included the fixed effects of treatment 
and period, and the random effects of animal and block (age).  All treatment least squares 
means were compared using contrasts that tested for linear and quadratic effects of 
incremental dietary supplementation of barley.  Fecal concentrations of agmatine, 
cadaverine, tryptamine, total biogenic amines, 4-ethylphenol, P-cresol, isobutyrate, 
isovalerate and total branched-chain fatty acids (BCFA) were not normally distributed, so 
a log transformation was applied for statistical analysis.  Differences between means with 
P<0.05 were considered significant and means with P0.10 were considered tendencies. 
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RESULTS 
Nutrient Intake and Digestibility, and Fecal Scores 
 Dry matter (DM) intake (Table 5.2) was based on their metabolizable energy 
requirements for maintenance thus, it was consistent across dietary treatments.  Total 
dietary fiber (TDF) intake increased quadratically with incremental addition of barley 
(p=0.001), while acid hydrolized fat (AHF) intake did not differ among treatments.  
Despite the differences in TDF intake, fecal DM and TDF output were not different 
among dietary treatments.  Fecal AHF output tended to increase quadratically as dietary 
barley increased (p=0.0602).  Apparent DM digestibility was similar among treatments. 
Total dietary fiber digestibility increased quadratically (p=0.0307), being highest for 
BA20 and BA40 treatments, while AHF digestibility decreased in the same fashion 
(p=0.0344) with lowest values observed in the BA20 and BA40 treatments.  No 
differences were observed for fecal scores after 48h or 15d of feeding the experimental 
diets. 
 
Nitrogen Metabolism 
 Nitrogen (N) intake (Table 5.3) had a quadratic response (P<0.001), being lower 
in the CO and BA10 treatments than in the BA20 and BA40 treatments.  Fecal and urine 
N excretion were not different among treatments.  Nitrogen absorbed increased 
quadratically (p=0.0069), being lowest for CO and highest for the BA20 treatments.  
Nitrogen digestibility was unaffected by treatment whereas nitrogen retention tended to 
respond in a quadratic fashion (p=0.0524) being highest in the BA20 treatment and 
lowest in the BA10.  However, N balance was unaffected by treatment. 
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Fermentation Metabolites 
 Fecal concentrations of acetate (p=0.0364), propionate (p=0.0004), and total 
SCFA (p=0.0203) increased quadratically as the inclusion of barley increased.  In 
contrast, no treatment effect was observed for fecal concentration of butyrate or any of 
the BCFAs (Table 5.4). 
 Fecal concentration of 4-ethylphenol was unchanged among dietary treatments 
(Table 5.5), whereas P-cresol tended (quadratic, p=0.0599) to decrease as barley 
increased.  Biogenic amines were unaffected by dietary treatment. 
 
Postprandial Glycemic and Insulinemic Responses and Fasting Plasma 
Cholesterol Concentration 
 Incremental and decremental glucose AUC were not affected by the treatments 
(Table 5.6).  Likewise, insulin AUC did not differ among treatments and no difference in 
fasting plasma cholesterol were observed among different dietary treatments. 
DISCUSSION 
Carbohydrates are heterogeneous organic compounds that include low and high 
molecular weight sugars, starches, and various cell wall and storage non-starch 
polysaccharides or dietary fibers (Bach-Knudsen, 1997).  Because of their heterogeneity, 
carbohydrates can have different functional properties: absorbable, digestible, 
fermentable, and non-fermentable, which are the major contributors for modifying post-
prandial glucose and insulin curves in dogs and humans (Nguyen et al., 1994 and 
Wolever and Bolognesi, 1996).  In addition, fermentable dietary fibers have also shown 
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to exert hypolipidemic effects in human and rodent models (Queenan et al., 2007; 
Nishima et al., 1990) and to have the potential to improve the host health by increased 
SCFA production and decreased production of carcinogenic compounds in the hindgut 
(Swanson et al., 2002).  Because pets have become an essential family member in the 
American household, pet owners search for ways to maintain the health and to increase 
the longevity of their companion animals, as well as to discover new strategies to prevent 
or ameliorate common health conditions that affect the today’s pet population such as: 
diabetes mellitus, hyperlipidemia, insulin resistance, etc.  Thus, the aim of this study was 
to examine the effects of incremental levels of barley; rich in -glucans a highly 
fermentable type of dietary fiber, on apparent nutrient digestibility, fecal quality and 
odor, postprandial glycemic and insulinemic responses, and plasma cholesterol levels in 
adult dogs. 
 
Nutrient Intake and Digestibility, and Fecal Scores 
 The higher intake of TDF for the BA20 and BA40 treatments was anticipated and 
reflected the higher levels of fiber present in barley, mainly -glucans.  The observed 
quadratic increase of AHF output could possibly be a consequence of increased digesta 
viscosity in the small intestine, decreasing the effectiveness of enzymes related to the 
hydrolytic digestion of lipids in this site.  It could also be related to an increased 
excretion of cholesterol due to a decrease in its recycling from the lower small and large 
intestine into hepatic portal blood circulation.  Another possibility would be an increased 
lipid excretion due to higher excretion of microbial mass in feces.  Fermentable fibers 
augment fermentative processes, which may lead to a higher number of microbes in the 
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hindgut and consequently, a greater elimination of microbial cells in fecal matter that can 
result in a false negative effect of fermentable fibers in nutrient digestibility.  As 
discussed later in this chapter, N digestibility was not negatively affected by incremental 
levels of barley, suggesting that it is unlikely that the observed decrease in AHF 
digestibility would be related to increased excretion of microbial mass.  In support of our 
reasoning, higher ileal fat flow and fecal cholesterol excretion have been observed in 
ileum-cannulated pigs and humans after consumption of diets rich in -glucans (Knudsen 
et al., 1993 and Lia et al., 1995).  Despite the lower AHF digestibility observed with 
increased barley, AHF digestibility for all treatments was high and within and the 
expected range.  Only a numerical decrease in TDF output of approximately 16% was 
observed for the BA40 treatment.  The higher TDF digestibility of the BA40 diet, relates 
to the increased TDF intake and numerically lower TDF output; a consequence of the 
high fermentability of this substrate in the large intestine. 
 To our knowledge, no studies have been conducted looking at the effects of barley 
on nutrient digestibility in the canine model.  However, several studies looking at other 
sources of fermentable fibers (e.g. fructoologosacharides, inulin, and pectin) have been 
performed in dogs and cats (Faber et al., 2011; Barry et al., 2010; Barry et al., 2009; 
Flickinger et al., 2003; and Silvio et al., 2000).  In general, the data from these studies 
showed similar DM and AHF digestibilities ranging between 78-89% and 92.5-96%, 
respectively.  Silvio et al. (2000) reported a TDF digestibility of 69% in a diet with high 
levels of soluble fiber (10% pectin).  This result is comparable to the apparent TDF 
digestibility value obtained in the current study for the BA40 diet.  Because barley is rich 
in -glucans, which is a highly fermentable fiber source, a higher TDF digestibility was 
94 
anticipated with incremental inclusion of barley in the diets.  Based on these results it 
appears that inclusion of barley (up to 40%) is well tolerated by adult dogs and can be 
adopted by the pet food industry in the manufacturing of commercial diets.  In addition, 
studies looking at fecal DM digestibility of diets containing barley for swine have 
reported similar values ranging between 85.5-88% (Wilfart et al., 2007; Veum et al., 
2007; Woyengo et al., 2009).  In contrast, Wilfart et al. (2007) found lower fat (ether 
extract) and TDF digestibilities, 77 and 46%, respectively, for pigs fed a diet containing 
41.1% barley. 
 Fecal scores for dogs fed all dietary treatments within the desirable range 2-3.  
This result indicates that inclusion of barley at the levels utilized in this study did not 
compromise stool quality, which is an important factor in considering the suitability of an 
ingredient in pet food.  Currently, most dogs are indoors; causing pet owners to seek diets 
that result in small and well-shaped stools. 
Nitrogen Metabolism 
 The slightly increased concentrations of crude protein in the BA20 and BA40 
treatments led to the slight increase in N intake for these treatments.  Even though, the 
diets were formulated to be isonitrogenous, barley grain has higher crude protein value 
than corn, 12.3 and 8.4%, respectively; which led to higher dietary CP in the diets 
containing higher levels of barley.  The increased N absorbed for the BA20 and BA40 
diets would seem to be a consequence of the increased N intake as well.  Despite 
differences observed in N intake and absorption, N digestibility was not affected by 
treatment.  The N digestibilities of the current study are in agreement with literature 
values for N digestibility using the canine or feline models, which varied from 74 up to 
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90.5% (Faber et al., 2011; Barry et al., 2010; Barry et al., 2009; Flickinger et al., 2003; 
and Silvio et al., 2000).  Also in support of our data, studies investigating the impact of 
barley on nutrient digestibility in pigs, have found similar apparent fecal CP or N 
digestibilities, ranging from 83 up to 90% (O’Shea et al., 2011; Wilfart et al., 2007; 
Veum et al., 2007; Woyengo et al., 2009).  In this study, inclusion of barley up to 40% 
did not negatively impact nitrogen digestibility.  Similarly, inclusion of barley or oats in 
diets for broilers and cockerels, and pigs either improved or did not result in deleterious 
effects on N retention (O’Shea et al., 2011; Perttila et al., 2001). 
 
Fermentation Metabolites 
Direct measurement of fermentation in the canine hindgut is difficult; therefore 
fecal concentration of SCFA is used as an indirect measurement.  Even though changes in 
fecal SCFA profile or amount can be an indicative of increased or decreased colonic 
fermentative processes, fecal SCFA concentration may not always accurately reflect the 
amount produced.  Barley is rich in -glucans, which are rapidly fermented by the 
microbiota in the hindgut.  Therefore, increased SCFA production was expected as a 
result of higher rate of fermentative process at this site.  As dietary supplementation of 
barley increased, the fecal concentration of acetate, propionate, and total SCFA increased 
quadratically.  In support of our data, pigs fed with a variety of commercial barley had 
increased distal colon concentrations of acetate, propionate and total SCFA, while 
butyrate remained unchanged (Bird et al., 2004).  Other studies using canine or feline 
models have reported results similar to ours when animals were fed a source of 
fermentable fiber such as; beet pulp, fructooligosaccharides (FOS), galactoglucomannan, 
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mannanoligosaccharides (MOS), and pectin (Faber et al., 2011; Barry et al., 2010; 
Middelboss et al., 2007; Swanson et al., 2002;).  Several studies have reported no change 
or decreased levels of butyrate with dietary supplementation of fermentable fibers (Faber 
et al., 2011; Bird et al., 2004; Flickinger et al., 2003; Swanson et al., 2002; Silvio et al., 
2000), whereas others have found increased levels (Middelboss et al., 2007; Strickling et 
al., 2000; Sunvold et al., 1995).  It has been suggested that the fecal concentration of 
butyrate may not reflect fermentative processes due to its rapid absorption and utilization 
as an energy source by colonocytes (Swanson et al., 2002).  In agreement, in pigs fed 
different fiber sources (wheat bran, barley, and oat bran) higher numerical values were 
reported for SCFA at the cecum and proximal colon, when compared to mid and distal 
colon (Bird et al., 2004).  In general, molar distribution of SCFA (%) in the current study 
is similar to studies that evaluated different fermentable fiber sources; with acetate being 
the predominant fraction, followed by propionate and butyrate (Branning and Nyman, 
2011; Faber et al., 2011; Barry et al., 2010; Middelboss et al., 2007; Flickinger et al., 
2003; Swanson et al., 2002; Silvio et al., 2000). 
 Branched chain fatty acids (BCFA), phenol and indole components, as well as 
biogenic amines are derivatives of the fermentation of amino acids and peptides, mainly 
when energy is limiting in the large intestine (Middelbos et al., 2007; Macfarlane et al., 
1992).  These nitrogenous compounds are responsible for fecal odor and at certain extent 
may be deleterious to gut health (Swanson et al., 2002).  In the current study, inclusion of 
barley was expected to decrease the formation of these compounds, since it has been 
proposed that fermentable carbohydrates provide additional energy supply for the gut 
microbiota (Swanson et al., 2002).  However, differently than hypothesized, barley 
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supplementation did not influence fecal concentration of BCFAs.  In support of our 
findings, dietary supplementation of MOS and FOS did not affect fecal concentration of 
BCFAs in adult dogs (Middelbos et al., 2007; Flickinger et al., 2003; Swanson et al., 
2002).  Increased levels of isobutyrate, isovalerate, valerate, and total BCFA were seen 
after FOS and pectin supplementation for adult cats (Barry et al., 2010).  These data may 
be due to the fact that cats are strict carnivores, have a higher consumption of dietary 
protein, and generally a higher population of proteolytic bacteria (clostridial species) in 
their hindgut. 
 In the current study indole was detected in very few samples.  Fecal 
concentrations of 4-ethylphenol were not affected by treatment and p-cresol tended to be 
lower for the diets containing higher levels of barley.  Lower numerical P-cresol 
concentration was reported for dogs fed beet pulp and 1.5% FOS plus 1% cellulose, 
however, the absolute values reported were, approximately, 10 fold lower than ours 
(Middelboss et al., 2007).  No differences in biogenic amines were observed among 
dietary treatments, which agree with most of the canine literature that looked at the effect 
of fermentable fibers on these compounds (Middelbos et al., 2007; Flickinger et al., 2003; 
and Swanson et al., 2002).  Recently, Faber et al. (2011) suggested that increased levels 
or lack of change in amine concentration, may be viewed as beneficial to colonic health, 
since some of the biogenic amines (e.g., putrescine, spermine, and spermidine) can 
modulate apoptosis and cell turnover processes. 
 
98 
Postprandial Glycemic and Insulinemic Responses and Fasting Plasma 
Cholesterol Concentration 
 The health benefits associated with the consumption of -glucans have been well 
documented and accepted by FDA, allowing products containing 0.75g of -glucans per 
serving to claim health benefits against heart disease (FDA, 1997).  The mechanism for 
the beneficial effects of barley consumption have been related to increased digesta 
viscosity in the gastrointestinal tract and decreased gastric emptying rate, which leads to a 
lower absorption rate of glucose and to a increased excretion of cholesterol and dietary 
fat (Lia et al., 1995).  However, in this study no beneficial effects in postprandial 
glycemic and insulinemic responses were observed with incremental inclusion of barley.  
Factors that might have prevented our ability to detect differences among treatments 
could be related to the high variation in treatment response among dogs and the amount 
of -glucan supplemented in the test diets.  In barley (Hordeum vulgare L.), the amount 
of -glucans can be affected by varietal and environmental conditions (Stuart et al., 
1988).  Average -glucan content in barley has been reported to be approximately 4.2% 
(NRC, 2006).  Based on this value, the average daily intake of -glucan of dogs 
consuming the BA10, BA20, and BA40 diets would be 0.9, 1.9, 3.8 g/d, respectively.  
Thondre et al. (2009) suggested 4 g/d of dietary -glucan as an ideal dose to reduce 
glycemic response.  In contrast, a 12% inclusion of -glucan was needed before 
improvements in postprandial glycemia and insulinemia were observed (Ostman et al., 
2006). Although, the estimated -glucan concentration in the BA40 diet was close to the 
optimal dose proposed by Thondre et al. (2009).  The same authors also acknowledge that 
the amount of -glucan to lower glycemic response may differ among various food 
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products.  Therefore, additional research is required to determine the optimal level of 
barley -glucan to lower glycemic and insulinemic responses in dogs, as well as to verify 
the effects of food processing (e.g., extrusion, canning, and baking) and diet matrix on 
the chemical behavior of barley -glucans.  It has been reported differences in 
postprandial glycemia from subjects receiving liquid and solid supplementation of barley 
-glucans (Thondre et al., 2009; Panahi et al., 2007; Poppitt et al., 2007).  Different 
responses in postprandial glycemia and in product viscosity also have been observed after 
-glucans in barley have been processed using enzymatically or aqueous methods, with 
the former being the most efficacious to increase viscosity (Panahi et al., 2007).  Other 
researchers have also mentioned blunted effects of -glucans on glucose and insulin 
responses in diets that already have a lower glycemic response, e.g., pasta vs. bread 
(Bourdon et al., 1999; Jarvi et al., 1995).  It is also possible that other nutrients in the diet 
may influence postprandial glycemic response, for example, it has been suggested a 
positive synergistic effect of the dietary amylose and -glucan contents (Bourdon et al., 
1999).  In the current study, the CO diet used corn as the primary carbohydrate source.  
Corn is rich in amylose, which could have made more difficult to detect difference in 
postprandial responses among our treatments. 
 In the current study, fasting plasma cholesterol concentrations were within normal 
physiological range reported for adult healthy dogs, 3.6-5.4 mmol/L (Jones and Manella, 
1990).  The lack of response in fasting plasma cholesterol concentration by incremental 
levels of dietary barley could possibly be explained by the need of a higher consumption 
of -glucan, or the requirement of a longer experimental period, or the use of a 
hypercholesterolemic model.  Dietary supplementation of 6 g of oat -glucans decreased 
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total cholesterol and low density lipoprotein (LDL) levels in humans suffering from 
hypercholesterolemia (Queenan et al., 2007). 
  Overall, the inclusion of barley up to 40% in diets for adult dogs seems to cause 
no adverse effect on food intake or nutrient digestibility, which indicates that barley, is an 
adequate carbohydrate source to be used by the pet food industry.  In addition, inclusion 
of barley led to an increased fecal concentration of acetate, proprionate and total SCFA, 
which may be beneficial in promoting or maintaining gut health in these animals.  In the 
current study, however, no change was observed with dietary supplementation of -
glucans from barley on most of fecal metabolites from fermentative processes, on the 
attenuation of postprandial response of glucose and insulin, and on fasting plasma 
cholesterol concentration as it has been reported in other models (Behall et al., 2006; 
Wood et al., 1994; Braaten et al., 1991; Queenan et al., 2007; Anderson et al., 1990).  
Nonetheless, further research in this field is warranted before these nutraceutical effects 
of barley -glucans are ruled out in the canine model. 
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Table 5. 1.  Ingredient and analyzed nutrient composition of experimental diets. 
Treatments 
Control Barley 10 Barley 20 Barley 40 
Ingredients, % as fed basis 
Corn yellow whole 40.00 30.00 20.00 0.00 
Corn starch 27.82 27.82 27.82 27.82 
Poultry meal low ash 19.94 19.94 19.94 19.94 
Barley cracked 0.00 10.00 20.00 40.00 
Pork fat 8.53 8.53 8.53 8.53 
Cellulose 1.00 1.00 1.00 1.00 
Chicken liver digest 1.00 1.00 1.00 1.00 
Sodium chloride, iodized. 0.75 0.75 0.75 0.75 
Potassium chloride 0.62 0.62 0.62 0.62 
Choline chloride dry60 0.15 0.15 0.15 0.15 
Vitamin premix 2352 0.06 0.06 0.06 0.06 
Calcium carbonate 0.06 0.06 0.06 0.06 
Mineral premix 2305 a 0.04 0.04 0.04 0.04 
Antioxidant naturox plus 0.04 0.04 0.04 0.04 
     
Nutrients, DM basis     
Crude protein, % 19.0 19.3 19.6 20.2 
Acid hydrolized fat, % 15.0 14.8 14.7 14.3 
Ash, % 4.5 4.6 4.6 4.7 
Gross energy, Kcal/ kg 4,731.2 4,741.4 4,666.2 4,748.2 
Total dietary fiber, % 9.7 10.2 10.8 11.7 
Ca, % 0.6 0.6 0.6 0.6 
P, % 0.5 0.5 0.6 0.6 
K, % 0.7 0.7 0.7 0.7 
Na, % 0.4 0.4 0.4 0.4 
Cl, % 1.0 1.0 1.0 1.0 
Mg, ppm 0.1 0.1 0.1 0.1 
Zn, ppm 168.1 168.8 169.6 171.1 
I, ppm 1.8 1.8 1.8 1.7 
Se, ppm 0.5 0.5 0.5 0.5 
a Formulated to supply at least (g/kg of food): 0.6 Mg, 1.8 Na, 7.0 K, 7.6 Cl, (mg/kg of 
food) 211 Fe, 163 Zn, 13 Cu, 13 Mn, 0.4 Se, 1.5 I (IU/g of food) 18.2 Vitamin A, 1.0 
Vitamin D, 0.18 Vitamin E (mg/kg of food) 0.3 Biotin, 1484 Choline, 1.9 Folic acid, 62 
Niacin, 18 Pantothenic acid, 8.6 Pyridoxine, 8.0 Riboflavin, 41 Thiamin, and 0.13 
Vitamin B12 
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Table 5. 2.  Nutrient intake and apparent digestibility of total dietary fiber (TDF) and acid hydrolyzed fat (AHF) and 
fecal score for dogs fed control or barley-containing diets. 
Treatment    
Item CO BA10 BA20 BA40 SEM Linear Quadratic 
Intake, g/d   
Dry matter 214.8 217.6 219.3 227.8 6.30   
Total dietary fiber 20.8 22.2 23.7 26.7 0.79 0.0190 0.0001 
Acid hydrolyzed fat 32.3 32.0 32.2 32.5 0.93 0.3004 0.2425 
  
Excretion, g/d        
Dry matter 26.0 26.5 30.3 26.8 2.86 0.6144 0.5302 
Total dietary fiber 10.0 10.0 10.7 8.5 1.24 0.7427 0.4809 
Acid hydrolyzed fat 1.4 1.4 1.9 2.0 0.32 0.7428 0.0602 
        
Apparent digestibility, %   
Dry matter 87.2 87.4 86.3 87.9 1.59 0.8765 0.9405 
Total dietary fiber 49.9 54.3 56.0 67.7 7.64 0.5868 0.0303 
Acid hydrolyzed fat 95.5 95.5 94.0 94.0 0.93 0.6977 0.0344 
        
Fecal score – 48h 2.9 2.8 2.9 3.0 0.11 0.2847 0.3775 
Fecal score – 15d 2.8 2.9 2.8 2.9 0.05 0.4232 0.2756 
  SEM=pooled SEM, n =16. 
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Table 5. 3.  Nitrogen metabolism of dogs fed control (CO) or barley-containing diets. 
Treatments    
Item CO BA10 BA20 BA40 SEM Linear Quadratic 
Food N Intake, g/d 6.8 6.9 7.6 7.4 0.22 0.0116 0.0001  
Fecal N, g/d 1.3 1.2 1.4 1.4 0.15 0.8865 0.2559 
Urine N, g/d 4.3 4.6 4.2 4.8 0.31 0.7049 0.6860 
    
N Absorbed, g/d 5.5 5.6 6.3 6.1 0.24 0.2739 0.0069 
N Digestibility, % 80.7 81.5 81.2 80.8 2.37 0.7527 0.9013 
N Retained, g/d 1.3 0.9 1.8 1.2 0.23 0.6610 0.0524 
N balance, % 18.8 11.8 25.3 15.5 2.97 0.2317 0.2668 
 SEM=pooled SEM, n =16. 
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Table 5. 4.  Concentrations (mmol/g, DM basis) of fecal short-chain (SCFA) and branched-chain fatty acids (BCFA) for 
dogs fed a control (CO), or barley-containing diets. 
Treatment    
Item CO BA10 BA20 BA40 SEM Linear Quadratic 
SCFA   
Acetate 0.23 0.22 0.25 0.29 0.023 0.7431 0.0364 
Propionate 0.12 0.12 0.14 0.18 0.013 0.7604 0.0004 
Butyrate 0.06 0.05 0.05 0.06 0.008 0.1996 0.9830 
Total SCFA 0.40 0.39 0.43 0.53 0.042 0.7690 0.0203 
  
BCFA   
Isobutyrate1 0.01 0.01 0.01 0.01 0.001 0.3048 0.7780 
Isovalerate1 0.01 0.02 0.01 0.01 0.002 0.3140 0.1425 
Valerate 0.002 0.002 0.001 0.002 0.0005 0.1624 0.8342 
Total BCFA1 0.022 0.028 0.033 0.026 0.0641 0.2004 0.7924 
1 Mean values reported are from not transformed data. SEM=pooled SEM, n =16. 
 
  
105 
Table 5. 5.  Fecal score, concentrations (DM basis) of fecal 4-ethylphenol, p-cresol and biogenic amines for dogs fed 
control (CO) or barley-containing diets. 
Treatment    
Item CO BA10 BA20 BA40 SEM Linear Quadratic 
4-ethylphenol, ug/g1 50.0 148.9 78.2 42.4 48.09 0.4206 0.5105 
P-cresol, ug/g1 336.6 398.1 256.3 270.1 44.25 0.6154 0.0599 
  
Biogenic amines, mg/g   
Agmatine 1 0.5 0.2 1.1 0.4 0.21 0.4866 0.1983 
Cadaverine1 2.6 1.7 6.7 3.5 1.51 0.9059 0.3655 
Putrescine 2.3 2.0 3.1 2.3 0.44 0.9919 0.3584 
Spermidine 1.0 1.1 0.9 1.3 0.23 0.9592 0.5208 
Spermine 1.0 1.2 0.7 0.9 0.23 0.8433 0.2075 
Tryptamine1 1.0 0.7 1.5 0.4 0.49 0.8073 0.6633 
Total1 8.4 6.7 14.6 8.6 2.75 0.8974 0.3452 
1 Mean values reported are from not transformed data. SEM=pooled SEM, n =16. 
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Table 5. 6. Postprandial glycemic and insulinemic responses, and fasting plasma cholesterol levels of dogs fed control (CO) 
or barley-containing diets. 
Treatment    
Item CO BA10 BA20 BA40 SEM Linear Quadratic 
Incremental Glucose AUC 192.1 177.6 218.2 181.9 49.24 0.9658 0.7492 
Decremental Glucose AUC 97.5 34.3 183.9 45.15 96.42 0.6745 0.9996 
         
Insulin AUC 363.8 594.6 548.0 546.5 115.44 0.1576 0.6878 
  
Cholesterol, mmol/L 4.3 4.4 4.3 4.3 0.15 0.3800 0.5338 
   SEM=pooled SEM, n =16. 
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CHAPTER 6: SUMMARY AND CONCLUSIONS 
 
Nowadays, the role played by pets in the American household is very different 
from when dogs were first domesticated. In the course of these 14,000y of domestication, 
the dog moved from being a working animal (e.g., hunting, herding, protection, etc.) to 
become Men’s best friend. In this process, a strong emotional human-animal bond was 
developed and the dog assumed a pivotal role in the families’ systems.  Pets became a 
source of emotional and psychological support, were brought inside of the homes and 
started sharing the same environment, food, and life style as of their owners.  Ironically, 
in this process many human health maladies have also been manifested in pets.  Among 
them, obesity and other chronic diseases such as: diabetes mellitus, hyperlipidemia, 
arthritis, etc. 
In order to address or to prevent these health issues, human and pet populations 
have been encouraged to modify their eating habits and increase their physical activity.  
All of which, have shown low success rates as many of these ailments still increasing in 
both populations.  An alternative strategy has been the modification of dietary nutrient 
composition.  Different lipid and carbohydrate sources have shown to be beneficial in 
ameliorating some of these chronic health conditions.  Among them fish oil and -
glucans have received considerable attention in human nutrition. 
The overall objectives of this research were to evaluate how different nutritional 
approaches, lipid or carbohydrate dietary modification by the use of fish oil or barley 
(rich in -glucans), would affect several parameters related to lipid, protein, and 
carbohydrate metabolism, which could be an useful tool during the management or in the 
prevention of chronic diseases such as, hyperlipidemia and insulin insensitivity, that 
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affect a large portion of the canine pet population.  In the first experiment, the effect of 
feeding a fish oil containing diet on lipid and protein metabolism, postprandial glycemia, 
and body weight in mature overweight dogs was examined.  Seven female dogs were 
randomly assigned to one of two isonitrogenous and isocaloric diets, control (CO) or fish 
oil (FO), in a crossover design.  Overall, the FO diet seemed an effective strategy to 
decrease cholesterol and might improve glucose clearance rate in mature overweight 
dogs. 
Similarly to the previous experiment, the second experiment aimed to assess how 
fish oil supplementation may affect lipid and protein metabolism, postprandial glycemia, 
and body weight in young lean adult dogs. In this study, eight female Beagles were 
randomly assigned to one of two isonitrogenous and isocaloric diets, control (CO) or fish 
oil (FO), in a crossover design.  Feeding FO containing to young adult dogs showed a 
protective effect against the rise of plasma CHOL and it increased plasma ghrelin levels.  
However, it did not appear to improve protein metabolism or postprandial glycemia in 
adult lean dogs. 
A different nutritional approach was used in the third experiment, which had the 
objective to examine the effects of incremental levels of barley on apparent nutrient 
digestibility, fecal short chain fatty acid concentrations, fecal quality and odor, 
postprandial glycemic and insulinemic responses, and plasma cholesterol levels in adult 
dogs.  Sixteen female dogs; eight purpose-bred mature female dogs and eight female 
Beagles were randomly assigned to four experimental diets; control (40% corn) or three 
levels of barley (10, 20, 40%).  The data gathered in this experiment suggested that 
inclusion of barley up to 40% in diets for adult dogs was well tolerated and did not 
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negatively impact nutrient digestibility of the diets.  In addition, dietary supplementation 
of barley might be beneficial in promoting gut health due to increased production of 
SCFA at this site; as suggested by the increased fecal concentration of these compounds.  
However, inclusion of barley (at the levels tested in this study) did not influence aspects 
related to fecal odor, postprandial glycemia, and plasma cholesterol. 
In conclusion, the body of research presented herein suggests that different 
nutritional strategies - dietary lipid or carbohydrate manipulation - may be beneficial in 
ameliorating health issues (e.g., hyperlipidemia) or in improving the health status of dogs 
(e.g., gut health by increased SCFA production).  In addition, no deleterious effects in 
nutrient digestibility were observed due to the incorporation of barley (up to 40%) or fish 
oil (2%) in the diets fed to adult dogs.  The data gathered in this dissertation offer 
valuable information for the pet food industry, as well as for pet owners seeking for novel 
nutraceutical ingredients as a mean to enhance the health and longevity of their 
companion animals or to aid in the management of common maladies noted in today’s 
pet population: hyperlipidemia, insulin resistance, diabetes mellitus, among others.  
Further research is necessary to determine optimal levels of supplementation of fish oil 
and barley to improve glycemic response and insulin sensitivity in the canine models and 
to advance our understanding on the metabolic processes involved in the onset of these 
chronic diseases and to determine how and when they can be best addressed by 
nutritional intervention.  Future discovery of a broader array of nutraceutical ingredients 
in the prevention or control of these chronic health issues would help not only to increase 
the longevity and life quality of our beloved pets, but also of their owners as dogs have 
been a well accepted and utilized experimental model for humans.   
Copyright © Maria Regina Cattai de Godoy 2011 
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